Agios Pharmaceuticals Inc. (AGIO) NASDAQ
$35.18 1.04 (3.05%)
Market Cap: $2B
As of 05/15/24 04:00 PM EDT. Market closed.
Agios Pharmaceuticals Inc. (AGIO)
NASDAQ
$35.18
1.04 (3.05%)
Market Cap: $2B
As of 05/15/24 04:00 PM EDT. Market closed.
at agios, we are doing incredibly important and difficult work. we are trying to discover and develop breakthrough medicines, and we have a clear motivator — people with cancer and rare genetic diseases who are counting on us to be successful. we are a science-driven research organization. we have built a discovery platform upon our expertise in the fields of cellular metabolism and precision ... read more
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
FOUSE JACQUALYN A | Director | Apr 10, 2024 | Sale | $27.55 | 7,791 | 214,642 | 137,396 | Apr 10, 2024, 04:03 PM |
Foster-Cheek Kaye I | Director | Mar 07, 2024 | Sale | $31.62 | 1,285 | 40,632 | 5,524 | Mar 11, 2024, 04:09 PM |
Foster-Cheek Kaye I | Director | Mar 06, 2024 | Sale | $31.99 | 4,415 | 141,236 | 6,809 | Mar 07, 2024, 06:49 PM |
Foster-Cheek Kaye I | Director | Mar 05, 2024 | Sale | $32.21 | 300 | 9,663 | 11,224 | Mar 07, 2024, 06:49 PM |
Washburn Theodore James Jr. | Principal Accounting Officer | Mar 05, 2024 | Sale | $31.75 | 1,913 | 60,738 | 2,886 | Mar 07, 2024, 06:47 PM |
Burns James William | Chief Legal Officer | Mar 05, 2024 | Sale | $32.57 | 2,642 | 86,050 | 37,169 | Mar 05, 2024, 04:08 PM |
Schenkein David P | Director | Feb 27, 2024 | Option Exercise | $31.64 | 69,329 | 2,193,570 | 180,325 | Feb 29, 2024, 04:05 PM |
Schenkein David P | Director | Feb 27, 2024 | Sale | $34.67 | 69,329 | 2,403,592 | 122,854 | Feb 29, 2024, 04:05 PM |
Schenkein David P | Director | Feb 26, 2024 | Option Exercise | $31.64 | 20,411 | 645,804 | 143,265 | Feb 27, 2024, 04:04 PM |
Schenkein David P | Director | Feb 23, 2024 | Option Exercise | $31.64 | 47,731 | 1,510,209 | 170,585 | Feb 27, 2024, 04:04 PM |
Schenkein David P | Director | Feb 26, 2024 | Sale | $33.19 | 20,411 | 677,441 | 122,854 | Feb 27, 2024, 04:04 PM |
Schenkein David P | Director | Feb 23, 2024 | Sale | $33.05 | 47,731 | 1,577,510 | 122,854 | Feb 27, 2024, 04:04 PM |
Washburn Theodore James Jr. | Principal Accounting Officer | Feb 20, 2024 | Sale | $26.63 | 504 | 13,422 | 2,741 | Feb 22, 2024, 05:43 PM |
Gheuens Sarah | Chief Medical Officer | Feb 14, 2024 | Sale | $25.14 | 642 | 16,140 | 33,431 | Feb 14, 2024, 05:53 PM |
Burns James William | Chief Legal Officer | Feb 14, 2024 | Sale | $25.14 | 545 | 13,701 | 31,666 | Feb 14, 2024, 05:51 PM |
Washburn Theodore James Jr. | Principal Accounting Officer | Feb 14, 2024 | Sale | $25.14 | 273 | 6,863 | 3,245 | Feb 14, 2024, 05:50 PM |
Burns James William | Chief Legal Officer | Jan 24, 2024 | Sale | $21.64 | 1,708 | 36,961 | 30,378 | Jan 24, 2024, 04:25 PM |
Gheuens Sarah | Chief Medical Officer | Jan 24, 2024 | Sale | $21.64 | 1,708 | 36,961 | 31,911 | Jan 24, 2024, 04:24 PM |
Jones Cecilia | Chief Financial Officer | Jan 24, 2024 | Sale | $21.64 | 1,886 | 40,813 | 13,069 | Jan 24, 2024, 04:23 PM |
FOUSE JACQUALYN A | Director | Jan 24, 2024 | Sale | $21.64 | 10,722 | 232,024 | 129,253 | Jan 24, 2024, 04:22 PM |
Goff Brian | Chief Executive Officer | Jan 24, 2024 | Sale | $21.64 | 7,635 | 165,221 | 49,436 | Jan 24, 2024, 04:20 PM |
Milanova Tsveta | Chief Commercial Officer | Jan 24, 2024 | Sale | $21.64 | 1,618 | 35,014 | 13,234 | Jan 24, 2024, 04:19 PM |
Goff Brian | Chief Executive Officer | Jan 09, 2024 | Sale | $22.99 | 12,066 | 277,397 | 40,053 | Jan 09, 2024, 04:28 PM |
FOUSE JACQUALYN A | Director | Jan 09, 2024 | Sale | $22.99 | 8,391 | 192,909 | 116,075 | Jan 09, 2024, 04:26 PM |
Burns James William | Chief Legal Officer | Jan 09, 2024 | Sale | $22.99 | 1,163 | 26,737 | 26,336 | Jan 09, 2024, 04:25 PM |
Gheuens Sarah | Chief Medical Officer | Jan 09, 2024 | Sale | $22.99 | 1,789 | 41,129 | 27,869 | Jan 09, 2024, 04:22 PM |
Milanova Tsveta | Chief Commercial Officer | Jan 05, 2024 | Sale | $22.32 | 2,902 | 64,773 | 9,404 | Jan 05, 2024, 04:10 PM |
Jones Cecilia | Chief Financial Officer | Sep 28, 2023 | Sale | $24.79 | 2,179 | 54,017 | 9,575 | Sep 28, 2023, 04:02 PM |
Burns James William | Chief Legal Officer | Aug 17, 2023 | Sale | $26.28 | 6,395 | 168,061 | 23,890 | Aug 21, 2023, 04:03 PM |
Foster-Cheek Kaye I | Director | Aug 09, 2023 | Option Exercise | $18.09 | 25,000 | 452,250 | 36,524 | Aug 11, 2023, 04:04 PM |
Foster-Cheek Kaye I | Director | Aug 09, 2023 | Sale | $25.96 | 25,000 | 648,887 | 11,524 | Aug 11, 2023, 04:04 PM |
Goff Brian | Chief Executive Officer | Aug 08, 2023 | Sale | $25.48 | 10,178 | 259,335 | 26,592 | Aug 10, 2023, 04:07 PM |
Washburn Theodore James Jr. | Principal Accounting Officer | Aug 07, 2023 | Sale | $25.39 | 2,918 | 74,096 | 2,741 | Aug 09, 2023, 04:04 PM |
Washburn Theodore James Jr. | Principal Accounting Officer | Aug 01, 2023 | Sale | $26.26 | 1,232 | 32,352 | 5,659 | Aug 02, 2023, 04:02 PM |
Burns James William | Chief Legal Officer | Jun 30, 2023 | Sale | $28.36 | 1,707 | 48,411 | 30,285 | Jun 30, 2023, 04:09 PM |
FOUSE JACQUALYN A | Director | Jun 30, 2023 | Sale | $28.36 | 10,718 | 303,962 | 106,966 | Jun 30, 2023, 04:07 PM |
Gheuens Sarah | Chief Medical Officer | Jun 30, 2023 | Sale | $28.36 | 1,707 | 48,411 | 24,159 | Jun 30, 2023, 04:06 PM |
Goff Brian | Chief Executive Officer | Jun 30, 2023 | Sale | $28.36 | 11,449 | 324,694 | 14,079 | Jun 30, 2023, 04:05 PM |
Jones Cecilia | Chief Financial Officer | Jun 30, 2023 | Sale | $28.36 | 1,597 | 45,291 | 3,783 | Jun 30, 2023, 04:03 PM |
Milanova Tsveta | Chief Commercial Officer | Jun 30, 2023 | Sale | $28.36 | 1,618 | 45,886 | 3,831 | Jun 30, 2023, 04:02 PM |
FOUSE JACQUALYN A | Director | Apr 12, 2023 | Option Exercise | $21.35 | 4,731 | 101,007 | 93,784 | Apr 12, 2023, 04:17 PM |
Schenkein David P | Director | Apr 03, 2023 | Option Exercise | $9.05 | 16,363 | 148,085 | 134,242 | Apr 05, 2023, 04:03 PM |
Schenkein David P | Director | Apr 03, 2023 | Sale | $22.85 | 16,363 | 373,895 | 117,879 | Apr 05, 2023, 04:03 PM |
Schenkein David P | Director | Mar 27, 2023 | Option Exercise | $9.05 | 20,000 | 181,000 | 137,879 | Mar 29, 2023, 09:30 PM |
Schenkein David P | Director | Mar 27, 2023 | Sale | $22.15 | 20,000 | 443,000 | 117,879 | Mar 29, 2023, 09:30 PM |
Schenkein David P | Director | Mar 13, 2023 | Option Exercise | $9.05 | 20,000 | 181,000 | 137,879 | Mar 15, 2023, 05:11 PM |
Schenkein David P | Director | Mar 13, 2023 | Sale | $22.49 | 20,000 | 449,817 | 119,546 | Mar 15, 2023, 05:11 PM |
Washburn Theodore James Jr. | Principal Accounting Officer | Mar 03, 2023 | Sale | $24.29 | 504 | 12,242 | 2,741 | Mar 07, 2023, 04:02 PM |
Gheuens Sarah | Chief Medical Officer | Mar 03, 2023 | Option Exercise | $25.02 | 1,134 | 28,373 | 20,116 | Mar 03, 2023, 04:05 PM |
Washburn Theodore James Jr. | Principal Accounting Officer | Feb 14, 2023 | Option Exercise | $28.91 | 127 | 3,672 | 3,405 | Feb 16, 2023, 04:04 PM |
Washburn Theodore James Jr. | Principal Accounting Officer | Feb 14, 2023 | Sale | $28.59 | 504 | 14,409 | 2,901 | Feb 16, 2023, 04:04 PM |
Burns James William | Chief Legal Officer | Feb 16, 2023 | Option Exercise | $28.91 | 609 | 17,606 | 23,538 | Feb 16, 2023, 04:04 PM |
FOUSE JACQUALYN A | Director | Feb 16, 2023 | Option Exercise | $28.91 | 3,648 | 105,464 | 82,582 | Feb 16, 2023, 04:03 PM |
Schenkein David P | Director | Feb 13, 2023 | Option Exercise | $9.05 | 20,000 | 181,000 | 137,879 | Feb 15, 2023, 04:03 PM |
Schenkein David P | Director | Feb 13, 2023 | Sale | $28.62 | 20,000 | 572,400 | 117,879 | Feb 15, 2023, 04:03 PM |
Burns James William | Chief Legal Officer | Feb 14, 2023 | Option Exercise | $28.44 | 643 | 18,287 | 22,409 | Feb 14, 2023, 04:07 PM |
Washburn Theodore James Jr. | Principal Accounting Officer | Feb 14, 2023 | Option Exercise | $28.44 | 273 | 7,764 | 3,172 | Feb 14, 2023, 04:06 PM |
Schenkein David P | Director | Jan 30, 2023 | Option Exercise | $9.05 | 20,000 | 181,000 | 137,879 | Feb 01, 2023, 04:04 PM |
Schenkein David P | Director | Jan 30, 2023 | Sale | $29.33 | 20,000 | 586,578 | 121,179 | Feb 01, 2023, 04:04 PM |
Schenkein David P | Director | Jan 17, 2023 | Option Exercise | $9.05 | 20,000 | 181,000 | 137,879 | Jan 19, 2023, 04:03 PM |
Schenkein David P | Director | Jan 17, 2023 | Sale | $28.85 | 20,000 | 577,093 | 118,913 | Jan 19, 2023, 04:03 PM |
Burns James William | Chief Legal Officer | Dec 28, 2022 | Option Exercise | $28.48 | 2,597 | 73,963 | 21,218 | Dec 28, 2022, 04:05 PM |
Gheuens Sarah | Chief Medical Officer | Dec 28, 2022 | Option Exercise | $28.48 | 2,783 | 79,260 | 15,605 | Dec 28, 2022, 04:05 PM |
Gheuens Sarah | Chief Medical Officer | Dec 06, 2022 | Option Exercise | $28.83 | 248 | 7,150 | 9,013 | Dec 06, 2022, 04:14 PM |
Poddar Richa | Chief Commercial Officer | Oct 17, 2022 | Option Exercise | $27.48 | 1,485 | 40,808 | 8,508 | Oct 18, 2022, 04:17 PM |
Washburn Theodore James Jr. | Principal Accounting Officer | Feb 25, 2022 | Sale | $30.00 | 108 | 3,240 | 2,549 | Mar 01, 2022, 04:54 PM |
Gheuens Sarah | Chief Medical Officer | Feb 22, 2022 | Option Exercise | $29.08 | 955 | 27,771 | 7,768 | Feb 23, 2022, 04:12 PM |
Poddar Richa | Chief Commercial Officer | Feb 22, 2022 | Option Exercise | $29.08 | 742 | 21,577 | 4,441 | Feb 23, 2022, 04:11 PM |
Car Bruce | Chief Scientific Officer | Feb 22, 2022 | Option Exercise | $29.08 | 2,041 | 59,352 | 16,752 | Feb 23, 2022, 04:11 PM |
Biller Jonathan | Chief Financial Officer | Feb 22, 2022 | Option Exercise | $29.08 | 2,688 | 78,167 | 22,953 | Feb 23, 2022, 04:10 PM |
FOUSE JACQUALYN A | Chief Executive Officer | Feb 22, 2022 | Option Exercise | $29.08 | 3,674 | 106,840 | 74,897 | Feb 23, 2022, 04:10 PM |
Burns James William | Chief Legal Officer | Feb 22, 2022 | Option Exercise | $29.08 | 215 | 6,252 | 14,793 | Feb 23, 2022, 04:10 PM |
Schenkein David P | Director | Feb 22, 2022 | Option Exercise | $29.08 | 758 | 22,043 | 116,294 | Feb 23, 2022, 04:09 PM |
Washburn Theodore James Jr. | Principal Accounting Officer | Feb 22, 2022 | Option Exercise | $29.08 | 59 | 1,716 | 2,657 | Feb 23, 2022, 04:09 PM |
Washburn Theodore James Jr. | Principal Accounting Officer | Feb 16, 2022 | Sale | $30.81 | 233 | 7,179 | 2,549 | Feb 18, 2022, 04:56 PM |
FOUSE JACQUALYN A | Chief Executive Officer | Feb 14, 2022 | Option Exercise | $30.50 | 3,505 | 106,903 | 66,192 | Feb 16, 2022, 05:01 PM |
Burns James William | Chief Legal Officer | Feb 14, 2022 | Option Exercise | $30.50 | 2,155 | 65,728 | 14,284 | Feb 16, 2022, 05:01 PM |
Poddar Richa | Chief Commercial Officer | Feb 14, 2022 | Option Exercise | $30.50 | 590 | 17,995 | 2,641 | Feb 16, 2022, 05:00 PM |
Washburn Theodore James Jr. | Principal Accounting Officer | Feb 14, 2022 | Option Exercise | $30.50 | 127 | 3,874 | 3,286 | Feb 16, 2022, 05:00 PM |
Washburn Theodore James Jr. | Principal Accounting Officer | Feb 14, 2022 | Sale | $31.25 | 504 | 15,750 | 2,782 | Feb 16, 2022, 05:00 PM |
Gheuens Sarah | Chief Medical Officer | Feb 10, 2022 | Option Exercise | $31.42 | 758 | 23,820 | 5,452 | Feb 14, 2022, 04:09 PM |
Washburn Theodore James Jr. | Principal Accounting Officer | Feb 10, 2022 | Option Exercise | $31.42 | 273 | 8,579 | 3,019 | Feb 14, 2022, 04:08 PM |
Biller Jonathan | Chief Financial Officer | Feb 10, 2022 | Option Exercise | $31.42 | 1,349 | 42,392 | 17,118 | Feb 14, 2022, 04:08 PM |
Burns James William | Chief Legal Officer | Feb 10, 2022 | Option Exercise | $31.42 | 643 | 20,206 | 9,451 | Feb 14, 2022, 04:06 PM |
Poddar Richa | Chief Commercial Officer | Feb 10, 2022 | Option Exercise | $31.42 | 725 | 22,783 | 1,493 | Feb 14, 2022, 04:06 PM |
Car Bruce | Chief Scientific Officer | Jan 06, 2022 | Option Exercise | $32.58 | 1,205 | 39,259 | 9,325 | Jan 10, 2022, 04:06 PM |
Gheuens Sarah | Chief Medical Officer | Dec 02, 2021 | Option Exercise | $35.00 | 248 | 8,680 | 4,048 | Dec 07, 2021, 04:18 PM |
Biller Jonathan | Chief Financial Officer | Dec 03, 2021 | Option Exercise | $35.88 | 1,823 | 65,406 | 14,800 | Dec 07, 2021, 04:18 PM |
Alenson Carman | Principal Accounting Officer | Jun 21, 2021 | Option Exercise | $51.51 | 1,777 | 91,533 | 1,777 | Jun 23, 2021, 05:28 PM |
Alenson Carman | Principal Accounting Officer | Jun 21, 2021 | Sale | $61.61 | 1,777 | 109,481 | 0 | Jun 23, 2021, 05:28 PM |
Bowden Christopher | Chief Medical Officer | Jun 18, 2021 | Option Exercise | $49.99 | 48,493 | 2,423,991 | 63,980 | Jun 22, 2021, 04:44 PM |
Bowden Christopher | Chief Medical Officer | Jun 18, 2021 | Sale | $60.11 | 48,493 | 2,914,851 | 15,487 | Jun 22, 2021, 04:44 PM |
Miles Darrin | Chief Commercial Officer | May 14, 2021 | Sale | $55.41 | 3,462 | 191,829 | 7,209 | May 18, 2021, 04:11 PM |
Bowden Christopher | Chief Medical Officer | Apr 20, 2021 | Option Exercise | $35.76 | 14,401 | 515,024 | 29,888 | Apr 21, 2021, 05:11 PM |
Bowden Christopher | Chief Medical Officer | Apr 19, 2021 | Option Exercise | $35.16 | 3,210 | 112,864 | 18,697 | Apr 21, 2021, 05:11 PM |
Bowden Christopher | Chief Medical Officer | Apr 20, 2021 | Sale | $55.11 | 14,401 | 793,581 | 15,487 | Apr 21, 2021, 05:11 PM |
Bowden Christopher | Chief Medical Officer | Apr 19, 2021 | Sale | $55.16 | 3,210 | 177,055 | 15,487 | Apr 21, 2021, 05:11 PM |
Miles Darrin | Chief Commercial Officer | Mar 05, 2021 | Sale | $48.58 | 500 | 24,290 | 10,671 | Mar 16, 2021, 04:14 PM |
Miles Darrin | Chief Commercial Officer | Mar 01, 2021 | Sale | $47.99 | 2,200 | 105,578 | 11,171 | Mar 16, 2021, 04:14 PM |
Biller Jonathan | Chief Financial Officer | Dec 03, 2020 | Option Exercise | $45.87 | 1,707 | 78,300 | 10,040 | Dec 07, 2020, 06:21 PM |
Alenson Carman | Principal Accounting Officer | Sep 02, 2020 | Sale | $39.93 | 250 | 9,983 | 184 | Sep 04, 2020, 04:24 PM |
Bowden Christopher | Chief Medical Officer | May 20, 2020 | Option Exercise | $35.16 | 3,583 | 125,978 | 11,889 | May 21, 2020, 05:05 PM |
Bowden Christopher | Chief Medical Officer | May 20, 2020 | Sale | $50.01 | 3,583 | 179,200 | 8,306 | May 21, 2020, 05:05 PM |
Hirsch Andrew | Chief Financial Officer | Apr 22, 2020 | Option Exercise | $45.91 | 1,927 | 88,469 | 24,272 | Apr 24, 2020, 04:06 PM |
Biller Jonathan | Chief Legal Officer | Apr 14, 2020 | Option Exercise | $40.64 | 2,529 | 102,779 | 5,994 | Apr 15, 2020, 04:27 PM |
Hirsch Andrew | Chief Financial Officer | Apr 14, 2020 | Option Exercise | $40.64 | 1,599 | 64,983 | 20,306 | Apr 15, 2020, 04:26 PM |
FOUSE JACQUALYN A | Chief Executive Officer | Apr 14, 2020 | Option Exercise | $40.64 | 3,673 | 149,271 | 50,428 | Apr 15, 2020, 04:26 PM |
Car Bruce | Chief Scientific Officer | Apr 14, 2020 | Option Exercise | $40.64 | 2,027 | 82,377 | 4,847 | Apr 15, 2020, 04:25 PM |
Bowden Christopher | Chief Medical Officer | Apr 14, 2020 | Option Exercise | $40.64 | 2,368 | 96,236 | 8,230 | Apr 15, 2020, 04:25 PM |
Alenson Carman | Principal Accounting Officer | Mar 02, 2020 | Sale | $47.30 | 345 | 16,318 | 184 | Mar 04, 2020, 05:08 PM |
Alenson Carman | Principal Accounting Officer | Feb 26, 2020 | Sale | $47.12 | 472 | 22,241 | 184 | Feb 28, 2020, 04:17 PM |
Hirsch Andrew | Chief Financial Officer | Feb 24, 2020 | Option Exercise | $48.66 | 1,056 | 51,385 | 16,518 | Feb 25, 2020, 04:27 PM |
Bowden Christopher | Chief Medical Officer | Feb 24, 2020 | Option Exercise | $48.66 | 1,596 | 77,661 | 5,318 | Feb 25, 2020, 04:26 PM |
Schenkein David P | Director | Feb 24, 2020 | Option Exercise | $48.66 | 880 | 42,821 | 105,053 | Feb 25, 2020, 04:25 PM |
Alenson Carman | Principal Accounting Officer | Feb 24, 2020 | Option Exercise | $48.66 | 219 | 10,657 | 656 | Feb 25, 2020, 04:23 PM |
Alenson Carman | Principal Accounting Officer | Feb 20, 2020 | Sale | $53.37 | 2,427 | 129,529 | 184 | Feb 24, 2020, 04:02 PM |
Alenson Carman | Principal Accounting Officer | Feb 18, 2020 | Option Exercise | $52.01 | 1,163 | 60,488 | 2,611 | Feb 19, 2020, 04:55 PM |
Bowden Christopher | Chief Medical Officer | Feb 18, 2020 | Option Exercise | $52.01 | 819 | 42,596 | 3,581 | Feb 19, 2020, 04:53 PM |
Hirsch Andrew | Chief Financial Officer | Feb 18, 2020 | Option Exercise | $52.01 | 886 | 46,081 | 14,241 | Feb 19, 2020, 04:51 PM |
Schenkein David P | Director | Feb 18, 2020 | Option Exercise | $52.01 | 2,534 | 131,793 | 103,158 | Feb 19, 2020, 04:50 PM |
Bowden Christopher | Chief Medical Officer | Feb 11, 2020 | Option Exercise | $35.16 | 621 | 21,834 | 2,271 | Feb 13, 2020, 04:21 PM |
Bowden Christopher | Chief Medical Officer | Feb 11, 2020 | Sale | $50.02 | 621 | 31,063 | 1,650 | Feb 13, 2020, 04:21 PM |
Bowden Christopher | Chief Medical Officer | Feb 04, 2020 | Option Exercise | $35.16 | 8,526 | 299,774 | 15,841 | Feb 06, 2020, 04:52 PM |
Bowden Christopher | Chief Medical Officer | Feb 05, 2020 | Option Exercise | $35.16 | 35,447 | 1,246,317 | 37,097 | Feb 06, 2020, 04:52 PM |
Bowden Christopher | Chief Medical Officer | Feb 04, 2020 | Sale | $50.08 | 49,638 | 2,485,989 | 1,650 | Feb 06, 2020, 04:52 PM |
Alenson Carman | Principal Accounting Officer | Dec 26, 2019 | Sale | $50.09 | 2,950 | 147,766 | 184 | Dec 30, 2019, 04:08 PM |
FOUSE JACQUALYN A | Chief Executive Officer | Nov 13, 2019 | Buy | $31.00 | 40,322 | 1,249,982 | 41,722 | Nov 15, 2019, 04:05 PM |
Schenkein David P | Director | Nov 13, 2019 | Buy | $31.00 | 8,064 | 249,984 | 97,567 | Nov 15, 2019, 04:03 PM |
CELGENE CORP /DE/ | 10% Owner | Nov 12, 2019 | Buy | $31.00 | 403,225 | 12,499,975 | 1,777,824 | Nov 14, 2019, 04:06 PM |
Biller Scott | Chief Scientific Officer | Jun 11, 2019 | Option Exercise | $2.34 | 7,218 | 16,872 | 33,729 | Jun 13, 2019, 04:07 PM |
Biller Scott | Chief Scientific Officer | Apr 05, 2019 | Option Exercise | $39.76 | 3,000 | 119,280 | 29,511 | Apr 09, 2019, 04:59 PM |
Biller Scott | Chief Scientific Officer | Apr 05, 2019 | Sale | $67.71 | 3,000 | 203,135 | 27,110 | Apr 09, 2019, 04:59 PM |
Bowden Christopher | Chief Medical Officer | Apr 01, 2019 | Option Exercise | $35.16 | 10,000 | 351,600 | 17,238 | Apr 03, 2019, 04:12 PM |
Bowden Christopher | Chief Medical Officer | Apr 01, 2019 | Sale | $66.57 | 10,000 | 665,747 | 11,384 | Apr 03, 2019, 04:12 PM |
Bowden Christopher | Chief Medical Officer | Mar 15, 2019 | Option Exercise | $35.16 | 10,000 | 351,600 | 17,238 | Mar 19, 2019, 04:25 PM |
Bowden Christopher | Chief Medical Officer | Mar 15, 2019 | Sale | $64.16 | 10,000 | 641,615 | 8,538 | Mar 19, 2019, 04:25 PM |
Biller Scott | Chief Scientific Officer | Mar 05, 2019 | Option Exercise | $38.60 | 3,000 | 115,805 | 29,511 | Mar 07, 2019, 04:06 PM |
Biller Scott | Chief Scientific Officer | Mar 05, 2019 | Sale | $67.68 | 3,000 | 203,032 | 29,311 | Mar 07, 2019, 04:06 PM |
Hoerter Steven L. | Chief Commercial Officer | Mar 04, 2019 | Option Exercise | $39.76 | 5,000 | 198,800 | 15,941 | Mar 05, 2019, 04:04 PM |
Hoerter Steven L. | Chief Commercial Officer | Mar 01, 2019 | Option Exercise | $39.76 | 5,000 | 198,800 | 15,941 | Mar 05, 2019, 04:04 PM |
Hoerter Steven L. | Chief Commercial Officer | Mar 04, 2019 | Sale | $68.00 | 5,000 | 340,000 | 10,941 | Mar 05, 2019, 04:04 PM |
Hoerter Steven L. | Chief Commercial Officer | Mar 01, 2019 | Sale | $66.01 | 5,000 | 330,050 | 10,941 | Mar 05, 2019, 04:04 PM |
Biller Scott | Chief Scientific Officer | Feb 27, 2019 | Option Exercise | $15.10 | 9,000 | 135,875 | 35,511 | Mar 01, 2019, 04:02 PM |
Biller Scott | Chief Scientific Officer | Feb 27, 2019 | Sale | $65.00 | 9,000 | 585,000 | 26,511 | Mar 01, 2019, 04:02 PM |
Alenson Carman | Principal Accounting Officer | Feb 21, 2019 | Option Exercise | $56.33 | 1,016 | 57,231 | 2,796 | Feb 25, 2019, 04:03 PM |
Schenkein David P | Director | Feb 19, 2019 | Option Exercise | $58.03 | 2,471 | 143,392 | 89,503 | Feb 20, 2019, 04:07 PM |
Hoerter Steven L. | Chief Commercial Officer | Feb 19, 2019 | Option Exercise | $58.03 | 1,040 | 60,351 | 10,941 | Feb 20, 2019, 04:06 PM |
Hirsch Andrew | Chief Financial Officer | Feb 19, 2019 | Option Exercise | $58.03 | 821 | 47,643 | 12,374 | Feb 20, 2019, 04:05 PM |
Bowden Christopher | Chief Medical Officer | Feb 19, 2019 | Option Exercise | $58.03 | 818 | 47,469 | 7,195 | Feb 20, 2019, 04:04 PM |
Biller Scott | Chief Scientific Officer | Feb 19, 2019 | Option Exercise | $58.03 | 876 | 50,834 | 26,511 | Feb 20, 2019, 04:03 PM |
Alenson Carman | Principal Accounting Officer | Feb 19, 2019 | Option Exercise | $58.03 | 278 | 16,132 | 512 | Feb 20, 2019, 04:01 PM |
Alenson Carman | Principal Accounting Officer | Sep 28, 2018 | Sale | $76.45 | 152 | 11,620 | 0 | Feb 20, 2019, 04:01 PM |
Hirsch Andrew | Chief Financial Officer | Jan 22, 2019 | Option Exercise | $52.82 | 4,555 | 240,595 | 10,445 | Jan 23, 2019, 04:22 PM |
Hoerter Steven L. | Chief Commercial Officer | Jan 22, 2019 | Option Exercise | $52.82 | 5,769 | 304,719 | 9,231 | Jan 23, 2019, 04:19 PM |
Bowden Christopher | Chief Medical Officer | Jan 22, 2019 | Option Exercise | $52.82 | 1,960 | 103,527 | 5,229 | Jan 23, 2019, 04:12 PM |
Biller Scott | Chief Scientific Officer | Dec 21, 2018 | Option Exercise | $2.34 | 20,500 | 47,919 | 24,637 | Dec 26, 2018, 04:39 PM |
Biller Scott | Chief Scientific Officer | Nov 05, 2018 | Option Exercise | $9.05 | 3,000 | 27,150 | 53,932 | Nov 07, 2018, 04:09 PM |
Biller Scott | Chief Scientific Officer | Nov 05, 2018 | Sale | $69.69 | 3,000 | 209,071 | 51,732 | Nov 07, 2018, 04:09 PM |
Biller Scott | Chief Scientific Officer | Oct 05, 2018 | Option Exercise | $9.05 | 3,000 | 27,150 | 53,932 | Oct 09, 2018, 04:09 PM |
Biller Scott | Chief Scientific Officer | Oct 05, 2018 | Sale | $69.79 | 3,000 | 209,377 | 53,032 | Oct 09, 2018, 04:09 PM |
MARAGANORE JOHN | Director | Sep 12, 2018 | Sale | $71.74 | 14,162 | 1,015,982 | 22,047 | Sep 13, 2018, 04:01 PM |
MARAGANORE JOHN | Director | Sep 11, 2018 | Sale | $72.75 | 13,555 | 986,129 | 38,609 | Sep 13, 2018, 04:01 PM |
Schenkein David P | Chief Executive Officer | Sep 10, 2018 | Option Exercise | $31.64 | 8,730 | 276,217 | 83,849 | Sep 12, 2018, 12:00 AM |
Schenkein David P | Chief Executive Officer | Sep 05, 2018 | Option Exercise | $3.32 | 75,119 | 249,028 | 75,119 | Sep 07, 2018, 04:22 PM |
Alenson Carman | Principal Accounting Officer | Sep 05, 2018 | Option Exercise | $52.29 | 312 | 16,314 | 464 | Sep 07, 2018, 04:18 PM |
Alenson Carman | Principal Accounting Officer | Sep 05, 2018 | Sale | $83.00 | 312 | 25,896 | 152 | Sep 07, 2018, 04:18 PM |
Biller Scott | Chief Scientific Officer | Sep 05, 2018 | Option Exercise | $9.05 | 3,000 | 27,150 | 60,196 | Sep 07, 2018, 04:12 PM |
Biller Scott | Chief Scientific Officer | Sep 05, 2018 | Sale | $83.07 | 3,000 | 249,215 | 59,556 | Sep 07, 2018, 04:12 PM |
Bowden Christopher | Chief Medical Officer | Aug 30, 2018 | Option Exercise | $35.16 | 1,700 | 59,772 | 2,624 | Aug 31, 2018, 04:02 PM |
Bowden Christopher | Chief Medical Officer | Aug 29, 2018 | Option Exercise | $35.16 | 300 | 10,548 | 1,224 | Aug 31, 2018, 04:02 PM |
Bowden Christopher | Chief Medical Officer | Aug 30, 2018 | Sale | $80.03 | 1,700 | 136,051 | 924 | Aug 31, 2018, 04:02 PM |
Bowden Christopher | Chief Medical Officer | Aug 29, 2018 | Sale | $80.00 | 300 | 24,000 | 924 | Aug 31, 2018, 04:02 PM |
Hoerter Steven L. | Chief Commercial Officer | Aug 24, 2018 | Option Exercise | $39.76 | 2,050 | 81,508 | 2,050 | Aug 28, 2018, 04:06 PM |
Hoerter Steven L. | Chief Commercial Officer | Aug 24, 2018 | Sale | $74.92 | 2,050 | 153,586 | 0 | Aug 28, 2018, 04:06 PM |
Biller Scott | Chief Scientific Officer | Aug 06, 2018 | Option Exercise | $9.05 | 3,000 | 27,150 | 60,196 | Aug 08, 2018, 04:14 PM |
Biller Scott | Chief Scientific Officer | Aug 06, 2018 | Sale | $80.11 | 3,000 | 240,333 | 59,896 | Aug 08, 2018, 04:14 PM |
Hoerter Steven L. | Chief Commercial Officer | Jul 25, 2018 | Option Exercise | $39.76 | 2,050 | 81,508 | 2,050 | Jul 27, 2018, 04:01 PM |
Hoerter Steven L. | Chief Commercial Officer | Jul 25, 2018 | Sale | $84.58 | 2,050 | 173,389 | 0 | Jul 27, 2018, 04:01 PM |
Bowden Christopher | Chief Medical Officer | Jul 10, 2018 | Option Exercise | $35.16 | 2,000 | 70,320 | 2,924 | Jul 12, 2018, 04:14 PM |
Bowden Christopher | Chief Medical Officer | Jul 10, 2018 | Sale | $86.76 | 2,000 | 173,512 | 1,724 | Jul 12, 2018, 04:14 PM |
Alenson Carman | Principal Accounting Officer | Jul 09, 2018 | Option Exercise | $52.29 | 272 | 14,223 | 272 | Jul 11, 2018, 04:23 PM |
Alenson Carman | Principal Accounting Officer | Jul 09, 2018 | Sale | $84.94 | 272 | 23,104 | 0 | Jul 11, 2018, 04:23 PM |
Biller Scott | Chief Scientific Officer | Jul 05, 2018 | Option Exercise | $9.05 | 3,000 | 27,150 | 60,196 | Jul 09, 2018, 04:08 PM |
Biller Scott | Chief Scientific Officer | Jul 05, 2018 | Sale | $83.50 | 3,000 | 250,503 | 57,496 | Jul 09, 2018, 04:08 PM |
Hoerter Steven L. | Chief Commercial Officer | Jun 22, 2018 | Option Exercise | $39.76 | 2,050 | 81,508 | 2,050 | Jun 26, 2018, 04:02 PM |
Hoerter Steven L. | Chief Commercial Officer | Jun 22, 2018 | Sale | $97.58 | 2,050 | 200,039 | 0 | Jun 26, 2018, 04:02 PM |
Foster-Cheek Kaye I | Director | Jun 14, 2018 | Option Exercise | $50.73 | 9,000 | 456,570 | 11,200 | Jun 18, 2018, 04:05 PM |
Foster-Cheek Kaye I | Director | Jun 14, 2018 | Sale | $93.55 | 9,000 | 841,926 | 9,019 | Jun 18, 2018, 04:05 PM |
Bowden Christopher | Chief Medical Officer | Jun 12, 2018 | Option Exercise | $35.16 | 2,000 | 70,320 | 2,881 | Jun 14, 2018, 04:23 PM |
Bowden Christopher | Chief Medical Officer | Jun 12, 2018 | Sale | $92.89 | 2,000 | 185,786 | 1,081 | Jun 14, 2018, 04:23 PM |
Biller Scott | Chief Scientific Officer | Jun 05, 2018 | Option Exercise | $9.05 | 3,000 | 27,150 | 60,196 | Jun 07, 2018, 04:02 PM |
Biller Scott | Chief Scientific Officer | Jun 05, 2018 | Sale | $93.37 | 3,000 | 280,101 | 59,394 | Jun 07, 2018, 04:02 PM |
Schenkein David P | Chief Executive Officer | Jun 01, 2018 | Option Exercise | $0.48 | 13,000 | 6,280 | 13,000 | Jun 05, 2018, 04:10 PM |
Schenkein David P | Chief Executive Officer | Jun 01, 2018 | Sale | $95.35 | 13,000 | 1,239,608 | 11,490 | Jun 05, 2018, 04:10 PM |
Schenkein David P | Chief Executive Officer | May 30, 2018 | Option Exercise | $0.39 | 45,626 | 17,675 | 45,626 | Jun 01, 2018, 04:08 PM |
Schenkein David P | Chief Executive Officer | May 30, 2018 | Sale | $90.07 | 45,626 | 4,109,534 | 0 | Jun 01, 2018, 04:08 PM |
Schenkein David P | Chief Executive Officer | May 23, 2018 | Option Exercise | $0.30 | 49,374 | 14,936 | 49,374 | May 29, 2018, 06:17 AM |
Schenkein David P | Chief Executive Officer | May 23, 2018 | Sale | $90.40 | 49,374 | 4,463,524 | 9,600 | May 29, 2018, 06:17 AM |
Hoerter Steven L. | Chief Commercial Officer | May 23, 2018 | Option Exercise | $39.76 | 2,050 | 81,508 | 2,050 | May 29, 2018, 06:14 AM |
Hoerter Steven L. | Chief Commercial Officer | May 23, 2018 | Sale | $85.76 | 2,050 | 175,808 | 0 | May 29, 2018, 06:14 AM |
Biller Scott | Chief Scientific Officer | May 23, 2018 | Option Exercise | $31.64 | 15,177 | 480,200 | 72,373 | May 29, 2018, 06:11 AM |
Biller Scott | Chief Scientific Officer | May 23, 2018 | Sale | $90.00 | 15,177 | 1,365,930 | 57,196 | May 29, 2018, 06:11 AM |
Bowden Christopher | Chief Medical Officer | May 11, 2018 | Option Exercise | $35.16 | 2,000 | 70,320 | 2,881 | May 15, 2018, 04:13 PM |
Bowden Christopher | Chief Medical Officer | May 11, 2018 | Sale | $85.00 | 2,000 | 170,003 | 2,041 | May 15, 2018, 04:13 PM |
Bowden Christopher | Chief Medical Officer | May 08, 2018 | Option Exercise | $35.16 | 2,000 | 70,320 | 2,881 | May 10, 2018, 04:00 PM |
Bowden Christopher | Chief Medical Officer | May 08, 2018 | Sale | $81.38 | 2,000 | 162,760 | 881 | May 10, 2018, 04:00 PM |
Biller Scott | Chief Scientific Officer | May 07, 2018 | Option Exercise | $9.05 | 3,000 | 27,150 | 60,196 | May 08, 2018, 04:08 PM |
Biller Scott | Chief Scientific Officer | May 07, 2018 | Sale | $81.81 | 3,000 | 245,430 | 57,196 | May 08, 2018, 04:08 PM |
Schenkein David P | Chief Executive Officer | May 01, 2018 | Option Exercise | $0.30 | 13,000 | 3,933 | 13,000 | May 03, 2018, 04:07 PM |
Schenkein David P | Chief Executive Officer | May 01, 2018 | Sale | $83.04 | 13,000 | 1,079,500 | 2,914 | May 03, 2018, 04:07 PM |
Hoerter Steven L. | Chief Commercial Officer | Apr 23, 2018 | Option Exercise | $39.76 | 2,050 | 81,508 | 2,050 | Apr 25, 2018, 04:12 PM |
Hoerter Steven L. | Chief Commercial Officer | Apr 23, 2018 | Sale | $85.95 | 2,050 | 176,197 | 0 | Apr 25, 2018, 04:12 PM |
Bowden Christopher | Chief Medical Officer | Apr 12, 2018 | Option Exercise | $35.16 | 2,000 | 70,320 | 2,881 | Apr 16, 2018, 04:01 PM |
Bowden Christopher | Chief Medical Officer | Apr 12, 2018 | Sale | $85.09 | 2,000 | 170,190 | 1,581 | Apr 16, 2018, 04:01 PM |
Biller Scott | Chief Scientific Officer | Apr 05, 2018 | Option Exercise | $9.05 | 3,000 | 27,150 | 60,196 | Apr 09, 2018, 04:09 PM |
Biller Scott | Chief Scientific Officer | Apr 05, 2018 | Sale | $75.20 | 3,000 | 225,607 | 58,896 | Apr 09, 2018, 04:09 PM |
Schenkein David P | Chief Executive Officer | Apr 02, 2018 | Option Exercise | $0.30 | 13,000 | 3,933 | 13,000 | Apr 04, 2018, 04:03 PM |
Schenkein David P | Chief Executive Officer | Apr 02, 2018 | Sale | $77.72 | 13,000 | 1,010,357 | 11,443 | Apr 04, 2018, 04:03 PM |
Biller Scott | Chief Scientific Officer | Mar 28, 2018 | Option Exercise | $2.32 | 4,137 | 9,611 | 57,196 | Mar 30, 2018, 04:18 PM |
Hoerter Steven L. | Chief Commercial Officer | Mar 22, 2018 | Option Exercise | $39.76 | 2,050 | 81,508 | 2,050 | Mar 26, 2018, 04:01 PM |
Hoerter Steven L. | Chief Commercial Officer | Mar 22, 2018 | Sale | $84.65 | 2,050 | 173,533 | 0 | Mar 26, 2018, 04:01 PM |
Foster-Cheek Kaye I | Director | Mar 19, 2018 | Option Exercise | $47.33 | 6,800 | 321,844 | 9,000 | Mar 21, 2018, 04:04 PM |
Foster-Cheek Kaye I | Director | Mar 19, 2018 | Sale | $81.97 | 6,800 | 557,396 | 2,200 | Mar 21, 2018, 04:04 PM |
Scadden David | Director | Mar 16, 2018 | Buy | $83.44 | 200 | 16,688 | 571 | Mar 20, 2018, 04:43 PM |
Bowden Christopher | Chief Medical Officer | Mar 14, 2018 | Option Exercise | $35.16 | 2,000 | 70,320 | 2,881 | Mar 16, 2018, 04:50 PM |
Bowden Christopher | Chief Medical Officer | Mar 14, 2018 | Sale | $82.33 | 2,000 | 164,661 | 1,181 | Mar 16, 2018, 04:50 PM |
Biller Scott | Chief Scientific Officer | Mar 05, 2018 | Option Exercise | $9.05 | 3,000 | 27,150 | 56,059 | Mar 07, 2018, 04:10 PM |
Biller Scott | Chief Scientific Officer | Mar 05, 2018 | Sale | $83.08 | 3,000 | 249,229 | 55,659 | Mar 07, 2018, 04:10 PM |
Schenkein David P | Chief Executive Officer | Mar 01, 2018 | Option Exercise | $0.30 | 13,000 | 3,933 | 13,000 | Mar 05, 2018, 04:32 PM |
Schenkein David P | Chief Executive Officer | Mar 01, 2018 | Sale | $81.09 | 13,000 | 1,054,218 | 10,085 | Mar 05, 2018, 04:32 PM |
Foster-Cheek Kaye I | Director | Feb 26, 2018 | Option Exercise | $47.33 | 2,200 | 104,126 | 2,200 | Feb 28, 2018, 04:02 PM |
Hoerter Steven L. | Chief Commercial Officer | Feb 22, 2018 | Option Exercise | $39.76 | 2,050 | 81,508 | 2,050 | Feb 26, 2018, 04:45 PM |
Hoerter Steven L. | Chief Commercial Officer | Feb 22, 2018 | Sale | $78.63 | 2,050 | 161,191 | 0 | Feb 26, 2018, 04:45 PM |
Bowden Christopher | Chief Medical Officer | Feb 16, 2018 | Option Exercise | $35.16 | 2,000 | 70,320 | 2,881 | Feb 20, 2018, 12:00 AM |
Bowden Christopher | Chief Medical Officer | Feb 16, 2018 | Sale | $77.65 | 2,000 | 155,305 | 1,381 | Feb 20, 2018, 12:00 AM |
Biller Scott | Chief Scientific Officer | Feb 05, 2018 | Option Exercise | $8.87 | 3,000 | 26,601 | 56,059 | Feb 07, 2018, 04:05 PM |
Biller Scott | Chief Scientific Officer | Feb 05, 2018 | Sale | $76.04 | 3,000 | 228,128 | 55,260 | Feb 07, 2018, 04:05 PM |
Bowden Christopher | Chief Medical Officer | Feb 01, 2018 | Option Exercise | $35.16 | 2,000 | 70,320 | 2,881 | Feb 05, 2018, 04:43 PM |
Bowden Christopher | Chief Medical Officer | Feb 01, 2018 | Sale | $78.75 | 2,000 | 157,500 | 1,566 | Feb 05, 2018, 04:43 PM |
Schenkein David P | Chief Executive Officer | Feb 01, 2018 | Option Exercise | $0.30 | 13,000 | 3,933 | 13,000 | Feb 05, 2018, 04:40 PM |
Schenkein David P | Chief Executive Officer | Feb 01, 2018 | Sale | $78.75 | 13,000 | 1,023,756 | 4,460 | Feb 05, 2018, 04:40 PM |
CELGENE CORP /DE/ | 10% Owner | Jan 23, 2018 | Buy | $67.00 | 851,154 | 57,027,318 | 1,374,599 | Jan 31, 2018, 08:39 AM |
Schenkein David P | Chief Executive Officer | Jan 26, 2018 | Option Exercise | $0.30 | 23,572 | 7,131 | 23,572 | Jan 30, 2018, 04:26 PM |
Schenkein David P | Chief Executive Officer | Jan 26, 2018 | Sale | $81.09 | 23,572 | 1,911,494 | 14,335 | Jan 30, 2018, 04:26 PM |
Alenson Carman | Principal Accounting Officer | Jan 12, 2018 | Option Exercise | $52.29 | 2,150 | 112,424 | 2,150 | Jan 26, 2018, 04:23 PM |
Alenson Carman | Principal Accounting Officer | Jan 12, 2018 | Sale | $75.00 | 2,150 | 161,250 | 0 | Jan 26, 2018, 04:23 PM |
Schenkein David P | Chief Executive Officer | Jan 24, 2018 | Option Exercise | $0.30 | 20 | 6 | 20 | Jan 26, 2018, 04:22 PM |
Schenkein David P | Chief Executive Officer | Jan 24, 2018 | Sale | $80.01 | 20 | 1,600 | 0 | Jan 26, 2018, 04:22 PM |
Hoerter Steven L. | Chief Commercial Officer | Jan 23, 2018 | Option Exercise | $39.76 | 25,000 | 994,000 | 25,000 | Jan 25, 2018, 04:03 PM |
Hoerter Steven L. | Chief Commercial Officer | Jan 23, 2018 | Sale | $74.83 | 25,000 | 1,870,750 | 0 | Jan 25, 2018, 04:03 PM |
Schenkein David P | Chief Executive Officer | Jan 24, 2018 | Option Exercise | $0.30 | 13,533 | 4,094 | 13,533 | Jan 25, 2018, 04:03 PM |
Schenkein David P | Chief Executive Officer | Jan 23, 2018 | Option Exercise | $0.30 | 32,875 | 9,945 | 32,875 | Jan 25, 2018, 04:03 PM |
Schenkein David P | Chief Executive Officer | Jan 24, 2018 | Sale | $80.01 | 13,533 | 1,082,775 | 0 | Jan 25, 2018, 04:03 PM |
Schenkein David P | Chief Executive Officer | Jan 23, 2018 | Sale | $80.01 | 32,875 | 2,630,329 | 0 | Jan 25, 2018, 04:03 PM |
CELGENE CORP /DE/ | 10% Owner | Jan 23, 2018 | Buy | $67.00 | 851,154 | 57,027,318 | 1,374,599 | Jan 23, 2018, 04:35 PM |
Schenkein David P | Chief Executive Officer | Jan 16, 2018 | Option Exercise | $0.30 | 53,000 | 16,033 | 53,000 | Jan 16, 2018, 05:16 PM |
Schenkein David P | Chief Executive Officer | Jan 16, 2018 | Sale | $73.16 | 53,000 | 3,877,218 | 39,815 | Jan 16, 2018, 05:16 PM |
Biller Scott | Chief Scientific Officer | Jan 10, 2018 | Option Exercise | $0.47 | 3,000 | 1,403 | 56,059 | Jan 12, 2018, 04:34 PM |
Biller Scott | Chief Scientific Officer | Jan 10, 2018 | Sale | $65.00 | 3,000 | 195,000 | 53,059 | Jan 12, 2018, 04:34 PM |
Cantley Lewis Clayton Jr. | Director | Dec 07, 2017 | Sale | $60.21 | 919 | 55,332 | 80,146 | Dec 08, 2017, 04:23 PM |
Cantley Lewis Clayton Jr. | Director | Dec 07, 2017 | Sale | $60.21 | 919 | 55,332 | 80,106 | Dec 08, 2017, 04:23 PM |
Cantley Lewis Clayton Jr. | Director | Dec 06, 2017 | Sale | $58.60 | 1,000 | 58,597 | 80,892 | Dec 08, 2017, 04:23 PM |
Cantley Lewis Clayton Jr. | Director | Dec 06, 2017 | Sale | $58.60 | 1,000 | 58,596 | 80,851 | Dec 08, 2017, 04:23 PM |
Biller Scott | Chief Scientific Officer | Dec 06, 2017 | Option Exercise | $1.74 | 46,795 | 81,376 | 53,059 | Dec 08, 2017, 04:22 PM |
Schenkein David P | Chief Executive Officer | Dec 01, 2017 | Option Exercise | $0.30 | 6,000 | 1,815 | 6,000 | Dec 05, 2017, 04:28 PM |
Schenkein David P | Chief Executive Officer | Dec 01, 2017 | Sale | $61.55 | 6,000 | 369,288 | 400 | Dec 05, 2017, 04:28 PM |
Biller Scott | Chief Scientific Officer | Dec 01, 2017 | Option Exercise | $31.64 | 2,146 | 67,899 | 8,410 | Dec 05, 2017, 04:09 PM |
Biller Scott | Chief Scientific Officer | Dec 01, 2017 | Sale | $60.79 | 2,146 | 130,459 | 7,810 | Dec 05, 2017, 04:09 PM |
Cantley Lewis Clayton Jr. | Director | Nov 13, 2017 | Sale | $62.07 | 1,000 | 62,070 | 82,394 | Nov 15, 2017, 05:43 PM |
Cantley Lewis Clayton Jr. | Director | Nov 14, 2017 | Sale | $59.70 | 1,000 | 59,700 | 81,743 | Nov 15, 2017, 05:43 PM |
Cantley Lewis Clayton Jr. | Director | Nov 14, 2017 | Sale | $59.70 | 1,000 | 59,700 | 81,703 | Nov 15, 2017, 05:43 PM |
Cantley Lewis Clayton Jr. | Director | Nov 13, 2017 | Sale | $62.07 | 1,000 | 62,070 | 82,434 | Nov 15, 2017, 05:43 PM |
Biller Scott | Chief Scientific Officer | Nov 01, 2017 | Option Exercise | $31.64 | 2,146 | 67,899 | 8,410 | Nov 03, 2017, 04:01 PM |
Biller Scott | Chief Scientific Officer | Nov 01, 2017 | Sale | $62.69 | 2,146 | 134,522 | 8,310 | Nov 03, 2017, 04:01 PM |
Schenkein David P | Chief Executive Officer | Nov 01, 2017 | Option Exercise | $0.30 | 6,000 | 1,815 | 6,000 | Nov 03, 2017, 04:00 PM |
Schenkein David P | Chief Executive Officer | Nov 01, 2017 | Sale | $63.85 | 6,000 | 383,105 | 5,800 | Nov 03, 2017, 04:00 PM |
Cantley Lewis Clayton Jr. | Director | Oct 16, 2017 | Sale | $71.09 | 1,000 | 71,090 | 84,394 | Oct 18, 2017, 05:34 PM |
Cantley Lewis Clayton Jr. | Director | Oct 17, 2017 | Sale | $71.10 | 1,000 | 71,100 | 83,434 | Oct 18, 2017, 05:34 PM |
Cantley Lewis Clayton Jr. | Director | Oct 17, 2017 | Sale | $71.10 | 1,000 | 71,100 | 83,394 | Oct 18, 2017, 05:34 PM |
Cantley Lewis Clayton Jr. | Director | Oct 16, 2017 | Sale | $71.09 | 1,000 | 71,090 | 84,434 | Oct 18, 2017, 05:34 PM |
Biller Scott | Chief Scientific Officer | Oct 04, 2017 | Sale | $70.00 | 10,470 | 732,900 | 0 | Oct 05, 2017, 06:35 PM |
Schenkein David P | Chief Executive Officer | Oct 04, 2017 | Option Exercise | $0.30 | 80,000 | 24,200 | 80,000 | Oct 05, 2017, 06:33 PM |
Schenkein David P | Chief Executive Officer | Oct 04, 2017 | Sale | $70.14 | 80,000 | 5,611,200 | 0 | Oct 05, 2017, 06:33 PM |
Biller Scott | Chief Scientific Officer | Oct 02, 2017 | Option Exercise | $19.10 | 2,146 | 40,995 | 7,455 | Oct 04, 2017, 04:32 PM |
Biller Scott | Chief Scientific Officer | Oct 02, 2017 | Sale | $67.23 | 2,146 | 144,276 | 6,264 | Oct 04, 2017, 04:32 PM |
Schenkein David P | Chief Executive Officer | Oct 02, 2017 | Option Exercise | $0.30 | 6,000 | 1,815 | 6,000 | Oct 04, 2017, 04:29 PM |
Schenkein David P | Chief Executive Officer | Oct 02, 2017 | Sale | $66.76 | 6,000 | 400,560 | 0 | Oct 04, 2017, 04:29 PM |
Schenkein David P | Chief Executive Officer | Sep 18, 2017 | Option Exercise | $0.30 | 35,000 | 10,588 | 35,000 | Sep 20, 2017, 12:00 AM |
Schenkein David P | Chief Executive Officer | Sep 18, 2017 | Sale | $67.12 | 35,000 | 2,349,200 | 0 | Sep 20, 2017, 12:00 AM |
Cantley Lewis Clayton Jr. | Director | Sep 13, 2017 | Sale | $65.47 | 1,000 | 65,470 | 86,434 | Sep 15, 2017, 04:54 PM |
Cantley Lewis Clayton Jr. | Director | Sep 13, 2017 | Sale | $65.47 | 1,000 | 65,470 | 86,394 | Sep 15, 2017, 04:54 PM |
Cantley Lewis Clayton Jr. | Director | Sep 14, 2017 | Sale | $65.71 | 1,000 | 65,710 | 85,434 | Sep 15, 2017, 04:54 PM |
Cantley Lewis Clayton Jr. | Director | Sep 14, 2017 | Sale | $65.71 | 1,000 | 65,710 | 85,394 | Sep 15, 2017, 04:54 PM |
Bowden Christopher | Chief Medical Officer | Sep 11, 2017 | Option Exercise | $35.16 | 6,000 | 210,960 | 6,881 | Sep 13, 2017, 04:38 PM |
Bowden Christopher | Chief Medical Officer | Sep 11, 2017 | Sale | $65.00 | 6,000 | 390,000 | 881 | Sep 13, 2017, 04:38 PM |
Biller Scott | Chief Scientific Officer | Sep 11, 2017 | Sale | $65.00 | 15,000 | 975,000 | 10,470 | Sep 13, 2017, 04:37 PM |
Biller Scott | Chief Scientific Officer | Sep 01, 2017 | Option Exercise | $9.05 | 2,146 | 19,421 | 8,410 | Sep 05, 2017, 05:25 PM |
Biller Scott | Chief Scientific Officer | Sep 01, 2017 | Sale | $61.99 | 2,146 | 133,031 | 6,264 | Sep 05, 2017, 05:25 PM |
Schenkein David P | Chief Executive Officer | Sep 01, 2017 | Option Exercise | $0.30 | 6,000 | 1,815 | 6,000 | Sep 05, 2017, 05:22 PM |
Schenkein David P | Chief Executive Officer | Sep 01, 2017 | Sale | $62.20 | 6,000 | 373,200 | 0 | Sep 05, 2017, 05:22 PM |
Cantley Lewis Clayton Jr. | Director | Aug 23, 2017 | Sale | $57.08 | 1,000 | 57,080 | 87,934 | Aug 24, 2017, 04:13 PM |
Cantley Lewis Clayton Jr. | Director | Aug 23, 2017 | Sale | $57.08 | 1,000 | 57,080 | 87,894 | Aug 24, 2017, 04:13 PM |
Cantley Lewis Clayton Jr. | Director | Aug 22, 2017 | Sale | $56.62 | 1,000 | 56,620 | 88,934 | Aug 24, 2017, 04:13 PM |
Cantley Lewis Clayton Jr. | Director | Aug 22, 2017 | Sale | $56.62 | 1,000 | 56,620 | 88,894 | Aug 24, 2017, 04:13 PM |
Biller Scott | Chief Scientific Officer | Aug 01, 2017 | Option Exercise | $9.05 | 2,146 | 19,421 | 8,410 | Aug 03, 2017, 05:29 PM |
Biller Scott | Chief Scientific Officer | Aug 02, 2017 | Sale | $60.06 | 21,000 | 1,261,260 | 25,470 | Aug 03, 2017, 05:29 PM |
Biller Scott | Chief Scientific Officer | Aug 01, 2017 | Sale | $55.05 | 2,146 | 118,137 | 6,264 | Aug 03, 2017, 05:29 PM |
Schenkein David P | Chief Executive Officer | Aug 02, 2017 | Option Exercise | $0.30 | 24,000 | 7,260 | 24,000 | Aug 03, 2017, 05:26 PM |
Schenkein David P | Chief Executive Officer | Aug 01, 2017 | Option Exercise | $0.30 | 3,000 | 908 | 3,000 | Aug 03, 2017, 05:26 PM |
Schenkein David P | Chief Executive Officer | Aug 02, 2017 | Sale | $60.55 | 24,000 | 1,453,200 | 0 | Aug 03, 2017, 05:26 PM |
Schenkein David P | Chief Executive Officer | Aug 01, 2017 | Sale | $55.12 | 3,000 | 165,360 | 0 | Aug 03, 2017, 05:26 PM |
Cantley Lewis Clayton Jr. | Director | Jul 20, 2017 | Sale | $57.13 | 1,000 | 57,125 | 85,737 | Jul 21, 2017, 04:05 PM |
Cantley Lewis Clayton Jr. | Director | Jul 20, 2017 | Sale | $57.13 | 1,000 | 57,125 | 85,697 | Jul 21, 2017, 04:05 PM |
Cantley Lewis Clayton Jr. | Director | Jul 19, 2017 | Sale | $56.14 | 3,500 | 196,505 | 86,737 | Jul 21, 2017, 04:05 PM |
Cantley Lewis Clayton Jr. | Director | Jul 19, 2017 | Sale | $56.14 | 3,500 | 196,505 | 86,697 | Jul 21, 2017, 04:05 PM |
Biller Scott | Chief Scientific Officer | Jul 07, 2017 | Option Exercise | $9.05 | 2,146 | 19,421 | 8,410 | Jul 11, 2017, 04:07 PM |
Biller Scott | Chief Scientific Officer | Jul 07, 2017 | Sale | $55.00 | 2,146 | 118,030 | 6,264 | Jul 11, 2017, 04:07 PM |
Schenkein David P | Chief Executive Officer | Jul 03, 2017 | Option Exercise | $0.30 | 3,000 | 908 | 3,000 | Jul 06, 2017, 04:31 PM |
Schenkein David P | Chief Executive Officer | Jul 03, 2017 | Sale | $51.18 | 3,000 | 153,540 | 0 | Jul 06, 2017, 04:31 PM |
Biller Scott | Chief Scientific Officer | Jun 23, 2017 | Option Exercise | $0.47 | 3,000 | 1,403 | 6,264 | Jun 27, 2017, 04:33 PM |
Biller Scott | Chief Scientific Officer | Jun 21, 2017 | Option Exercise | $5.52 | 7,292 | 40,245 | 4,556 | Jun 23, 2017, 04:08 PM |
Biller Scott | Chief Scientific Officer | Jun 21, 2017 | Sale | $55.00 | 4,292 | 236,060 | 264 | Jun 23, 2017, 04:08 PM |
Cantley Lewis Clayton Jr. | Director | Jun 14, 2017 | Sale | $51.09 | 500 | 25,545 | 89,697 | Jun 15, 2017, 05:02 PM |
Cantley Lewis Clayton Jr. | Director | Jun 13, 2017 | Sale | $50.64 | 500 | 25,320 | 90,237 | Jun 15, 2017, 05:02 PM |
Cantley Lewis Clayton Jr. | Director | Jun 13, 2017 | Sale | $50.64 | 500 | 25,320 | 90,197 | Jun 15, 2017, 05:02 PM |
Cantley Lewis Clayton Jr. | Director | Jun 14, 2017 | Sale | $51.09 | 500 | 25,545 | 89,737 | Jun 15, 2017, 05:02 PM |
Schenkein David P | Chief Executive Officer | Jun 07, 2017 | Option Exercise | $0.30 | 1,900 | 575 | 1,900 | Jun 08, 2017, 04:06 PM |
Schenkein David P | Chief Executive Officer | Jun 06, 2017 | Option Exercise | $0.30 | 1,100 | 333 | 1,100 | Jun 08, 2017, 04:06 PM |
Schenkein David P | Chief Executive Officer | Jun 07, 2017 | Sale | $50.02 | 1,900 | 95,038 | 0 | Jun 08, 2017, 04:06 PM |
Schenkein David P | Chief Executive Officer | Jun 06, 2017 | Sale | $50.02 | 1,100 | 55,022 | 0 | Jun 08, 2017, 04:06 PM |
Cantley Lewis Clayton Jr. | Director | May 25, 2017 | Sale | $46.92 | 509 | 23,882 | 90,737 | May 25, 2017, 07:03 PM |
Cantley Lewis Clayton Jr. | Director | May 25, 2017 | Sale | $46.92 | 509 | 23,882 | 90,697 | May 25, 2017, 07:03 PM |
Cantley Lewis Clayton Jr. | Director | May 24, 2017 | Sale | $47.27 | 509 | 24,060 | 91,246 | May 25, 2017, 07:03 PM |
Cantley Lewis Clayton Jr. | Director | May 24, 2017 | Sale | $47.27 | 509 | 24,060 | 91,206 | May 25, 2017, 07:03 PM |
Schenkein David P | Chief Executive Officer | May 01, 2017 | Option Exercise | $0.30 | 3,000 | 908 | 3,000 | May 02, 2017, 04:03 PM |
Schenkein David P | Chief Executive Officer | May 01, 2017 | Sale | $50.06 | 3,000 | 150,180 | 0 | May 02, 2017, 04:03 PM |
Celgene European Investment Co LLC | 10% Owner | Apr 24, 2017 | Buy | $49.50 | 624,575 | 30,916,463 | 1,856,353 | Apr 24, 2017, 04:34 PM |
Cantley Lewis Clayton Jr. | Director | Apr 18, 2017 | Sale | $50.92 | 509 | 25,918 | 91,755 | Apr 19, 2017, 05:16 PM |
Cantley Lewis Clayton Jr. | Director | Apr 18, 2017 | Sale | $50.92 | 509 | 25,918 | 91,715 | Apr 19, 2017, 05:16 PM |
Cantley Lewis Clayton Jr. | Director | Apr 17, 2017 | Sale | $55.24 | 2,036 | 112,458 | 93,791 | Apr 19, 2017, 05:16 PM |
Cantley Lewis Clayton Jr. | Director | Apr 17, 2017 | Sale | $55.24 | 2,036 | 112,458 | 93,751 | Apr 19, 2017, 05:16 PM |
Biller Scott | Chief Scientific Officer | Apr 03, 2017 | Option Exercise | $9.05 | 2,146 | 19,421 | 17,880 | Apr 05, 2017, 04:05 PM |
Biller Scott | Chief Scientific Officer | Apr 03, 2017 | Sale | $58.03 | 2,146 | 124,532 | 15,734 | Apr 05, 2017, 04:05 PM |
Schenkein David P | Chief Executive Officer | Apr 03, 2017 | Option Exercise | $0.30 | 3,000 | 908 | 3,000 | Apr 05, 2017, 04:04 PM |
Schenkein David P | Chief Executive Officer | Apr 03, 2017 | Sale | $58.62 | 3,000 | 175,860 | 0 | Apr 05, 2017, 04:04 PM |
Cantley Lewis Clayton Jr. | Director | Mar 23, 2017 | Sale | $53.91 | 509 | 27,440 | 94,300 | Mar 24, 2017, 04:20 PM |
Cantley Lewis Clayton Jr. | Director | Mar 23, 2017 | Sale | $53.91 | 509 | 27,440 | 94,260 | Mar 24, 2017, 04:20 PM |
Cantley Lewis Clayton Jr. | Director | Mar 22, 2017 | Sale | $52.31 | 509 | 26,626 | 94,809 | Mar 24, 2017, 04:20 PM |
Cantley Lewis Clayton Jr. | Director | Mar 22, 2017 | Sale | $52.31 | 509 | 26,626 | 94,769 | Mar 24, 2017, 04:20 PM |
Biller Scott | Chief Scientific Officer | Mar 20, 2017 | Option Exercise | $8.38 | 6,438 | 53,930 | 21,403 | Mar 22, 2017, 05:10 PM |
Biller Scott | Chief Scientific Officer | Mar 20, 2017 | Sale | $55.00 | 6,438 | 354,090 | 15,470 | Mar 22, 2017, 05:10 PM |
NELSEN ROBERT | Director | Mar 06, 2017 | Sale | $49.43 | 40 | 1,977 | 0 | Mar 07, 2017, 04:35 PM |
NELSEN ROBERT | Director | Mar 03, 2017 | Sale | $50.85 | 40,559 | 2,062,232 | 9,174 | Mar 07, 2017, 04:35 PM |
NELSEN ROBERT | Director | Feb 28, 2017 | Sale | $49.77 | 47,859 | 2,381,815 | 60,836 | Mar 01, 2017, 05:37 PM |
NELSEN ROBERT | Director | Feb 27, 2017 | Sale | $49.26 | 195,223 | 9,616,080 | 229,696 | Mar 01, 2017, 05:37 PM |
NELSEN ROBERT | Director | Feb 22, 2017 | Sale | $49.91 | 47,938 | 2,392,754 | 335,677 | Feb 23, 2017, 07:20 PM |
NELSEN ROBERT | Director | Feb 21, 2017 | Sale | $50.73 | 36,430 | 1,848,249 | 417,265 | Feb 23, 2017, 07:20 PM |
NELSEN ROBERT | Director | Feb 23, 2017 | Sale | $47.90 | 50,996 | 2,442,461 | 292,081 | Feb 23, 2017, 07:20 PM |
Schenkein David P | Chief Executive Officer | Feb 16, 2017 | Option Exercise | $0.30 | 6,000 | 1,815 | 6,000 | Feb 17, 2017, 04:36 PM |
Schenkein David P | Chief Executive Officer | Feb 16, 2017 | Sale | $50.01 | 6,000 | 300,060 | 0 | Feb 17, 2017, 04:36 PM |
Biller Scott | Chief Scientific Officer | Nov 14, 2016 | Option Exercise | $12.26 | 27,500 | 337,037 | 75,770 | Nov 16, 2016, 04:52 PM |
Biller Scott | Chief Scientific Officer | Nov 14, 2016 | Sale | $65.00 | 27,500 | 1,787,500 | 48,270 | Nov 16, 2016, 04:52 PM |
Biller Scott | Chief Scientific Officer | Nov 14, 2016 | Sale | $65.00 | 5,000 | 325,000 | 6,000 | Nov 16, 2016, 04:52 PM |
Biller Scott | Chief Scientific Officer | Nov 10, 2016 | Sale | $60.00 | 2,128 | 127,680 | 11,000 | Nov 14, 2016, 06:07 PM |
Biller Scott | Chief Scientific Officer | Nov 09, 2016 | Sale | $60.00 | 2,872 | 172,320 | 13,128 | Nov 14, 2016, 06:07 PM |
Cantley Lewis Clayton Jr. | Director | Oct 27, 2016 | Sale | $48.97 | 625 | 30,606 | 107,818 | Oct 28, 2016, 04:03 PM |
Cantley Lewis Clayton Jr. | Director | Oct 27, 2016 | Sale | $48.97 | 627 | 30,704 | 107,778 | Oct 28, 2016, 04:03 PM |
Cantley Lewis Clayton Jr. | Director | Oct 26, 2016 | Sale | $48.91 | 625 | 30,569 | 108,443 | Oct 28, 2016, 04:03 PM |
Cantley Lewis Clayton Jr. | Director | Oct 26, 2016 | Sale | $48.91 | 627 | 30,667 | 108,405 | Oct 28, 2016, 04:03 PM |
Biller Scott | Chief Scientific Officer | Oct 05, 2016 | Sale | $55.00 | 5,000 | 275,000 | 16,000 | Oct 06, 2016, 04:14 PM |
Cantley Lewis Clayton Jr. | Director | Sep 28, 2016 | Sale | $54.00 | 625 | 33,750 | 109,068 | Sep 28, 2016, 05:29 PM |
Cantley Lewis Clayton Jr. | Director | Sep 28, 2016 | Sale | $54.00 | 627 | 33,858 | 109,032 | Sep 28, 2016, 05:29 PM |
Cantley Lewis Clayton Jr. | Director | Sep 27, 2016 | Sale | $54.15 | 625 | 33,844 | 109,693 | Sep 28, 2016, 05:29 PM |
Cantley Lewis Clayton Jr. | Director | Sep 27, 2016 | Sale | $54.15 | 627 | 33,952 | 109,659 | Sep 28, 2016, 05:29 PM |
Biller Scott | Chief Scientific Officer | Sep 20, 2016 | Sale | $50.00 | 5,000 | 250,000 | 21,000 | Sep 22, 2016, 04:40 PM |
Cantley Lewis Clayton Jr. | Director | Aug 30, 2016 | Sale | $36.81 | 625 | 23,006 | 110,318 | Aug 31, 2016, 04:02 PM |
Cantley Lewis Clayton Jr. | Director | Aug 30, 2016 | Sale | $36.81 | 627 | 23,080 | 110,286 | Aug 31, 2016, 04:02 PM |
Cantley Lewis Clayton Jr. | Director | Aug 29, 2016 | Sale | $37.81 | 625 | 23,631 | 110,943 | Aug 31, 2016, 04:02 PM |
Cantley Lewis Clayton Jr. | Director | Aug 29, 2016 | Sale | $37.81 | 627 | 23,707 | 110,913 | Aug 31, 2016, 04:02 PM |
Cantley Lewis Clayton Jr. | Director | Jul 25, 2016 | Sale | $41.85 | 627 | 26,240 | 112,167 | Jul 27, 2016, 04:28 PM |
Cantley Lewis Clayton Jr. | Director | Jul 26, 2016 | Sale | $43.74 | 625 | 27,338 | 111,568 | Jul 27, 2016, 04:28 PM |
Cantley Lewis Clayton Jr. | Director | Jul 26, 2016 | Sale | $43.74 | 627 | 27,425 | 111,540 | Jul 27, 2016, 04:28 PM |
Cantley Lewis Clayton Jr. | Director | Jul 25, 2016 | Sale | $41.85 | 625 | 26,156 | 112,193 | Jul 27, 2016, 04:28 PM |
Cantley Lewis Clayton Jr. | Director | Jun 28, 2016 | Sale | $43.38 | 625 | 27,113 | 125,318 | Jun 29, 2016, 05:05 PM |
Cantley Lewis Clayton Jr. | Director | Jun 28, 2016 | Sale | $43.38 | 627 | 27,199 | 125,294 | Jun 29, 2016, 05:05 PM |
Cantley Lewis Clayton Jr. | Director | Jun 27, 2016 | Sale | $40.37 | 625 | 25,231 | 125,943 | Jun 29, 2016, 05:05 PM |
Cantley Lewis Clayton Jr. | Director | Jun 27, 2016 | Sale | $40.37 | 627 | 25,312 | 125,921 | Jun 29, 2016, 05:05 PM |
Biller Scott | Chief Scientific Officer | Jun 08, 2016 | Option Exercise | $6.36 | 27,500 | 174,766 | 86,570 | Jun 10, 2016, 04:03 PM |
Biller Scott | Chief Scientific Officer | Jun 10, 2016 | Option Exercise | $0.47 | 15,200 | 7,106 | 74,270 | Jun 10, 2016, 04:03 PM |
Biller Scott | Chief Scientific Officer | Jun 08, 2016 | Sale | $65.00 | 27,500 | 1,787,500 | 59,070 | Jun 10, 2016, 04:03 PM |
Cantley Lewis Clayton Jr. | Director | May 26, 2016 | Sale | $52.88 | 625 | 33,050 | 126,568 | May 27, 2016, 04:18 PM |
Cantley Lewis Clayton Jr. | Director | May 26, 2016 | Sale | $52.88 | 627 | 33,156 | 126,548 | May 27, 2016, 04:18 PM |
Cantley Lewis Clayton Jr. | Director | May 25, 2016 | Sale | $50.50 | 625 | 31,563 | 127,193 | May 27, 2016, 04:18 PM |
Cantley Lewis Clayton Jr. | Director | May 25, 2016 | Sale | $50.50 | 627 | 31,664 | 127,175 | May 27, 2016, 04:18 PM |
Cantley Lewis Clayton Jr. | Director | Apr 26, 2016 | Sale | $51.88 | 627 | 32,529 | 127,802 | Apr 27, 2016, 04:08 PM |
Cantley Lewis Clayton Jr. | Director | Apr 25, 2016 | Sale | $55.00 | 625 | 34,375 | 128,443 | Apr 27, 2016, 04:08 PM |
Cantley Lewis Clayton Jr. | Director | Apr 25, 2016 | Sale | $55.00 | 627 | 34,485 | 128,429 | Apr 27, 2016, 04:08 PM |
Cantley Lewis Clayton Jr. | Director | Apr 26, 2016 | Sale | $51.88 | 625 | 32,425 | 127,818 | Apr 27, 2016, 04:08 PM |
Cantley Lewis Clayton Jr. | Director | Mar 30, 2016 | Sale | $38.09 | 625 | 23,806 | 129,068 | Mar 31, 2016, 04:04 PM |
Cantley Lewis Clayton Jr. | Director | Mar 30, 2016 | Sale | $38.09 | 627 | 23,882 | 129,056 | Mar 31, 2016, 04:04 PM |
Cantley Lewis Clayton Jr. | Director | Mar 29, 2016 | Sale | $36.28 | 625 | 22,675 | 129,693 | Mar 31, 2016, 04:04 PM |
Cantley Lewis Clayton Jr. | Director | Mar 29, 2016 | Sale | $36.28 | 627 | 22,748 | 129,683 | Mar 31, 2016, 04:04 PM |
Cantley Lewis Clayton Jr. | Director | Nov 17, 2015 | Sale | $59.98 | 3,492 | 209,450 | 138,150 | Mar 23, 2016, 04:24 PM |
Cantley Lewis Clayton Jr. | Director | Nov 17, 2015 | Sale | $59.99 | 3,490 | 209,365 | 138,150 | Mar 23, 2016, 04:24 PM |
Cantley Lewis Clayton Jr. | Director | Nov 16, 2015 | Sale | $59.58 | 1,360 | 81,029 | 141,642 | Mar 23, 2016, 04:24 PM |
Cantley Lewis Clayton Jr. | Director | Nov 16, 2015 | Sale | $59.59 | 1,362 | 81,162 | 141,640 | Mar 23, 2016, 04:24 PM |
Cantley Lewis Clayton Jr. | Director | Feb 25, 2016 | Sale | $36.90 | 625 | 23,063 | 131,090 | Feb 29, 2016, 04:17 PM |
Cantley Lewis Clayton Jr. | Director | Feb 25, 2016 | Sale | $36.90 | 627 | 23,136 | 131,086 | Feb 29, 2016, 04:17 PM |
Cantley Lewis Clayton Jr. | Director | Feb 26, 2016 | Sale | $38.89 | 625 | 24,306 | 130,465 | Feb 29, 2016, 04:17 PM |
Cantley Lewis Clayton Jr. | Director | Feb 26, 2016 | Sale | $38.89 | 627 | 24,384 | 130,459 | Feb 29, 2016, 04:17 PM |
Biller Scott | Chief Scientific Officer | Feb 03, 2016 | Option Exercise | $0.47 | 10,000 | 4,675 | 59,070 | Feb 10, 2016, 04:54 PM |
Cantley Lewis Clayton Jr. | Director | Jan 29, 2016 | Sale | $41.52 | 625 | 25,950 | 131,715 | Feb 01, 2016, 05:56 PM |
Cantley Lewis Clayton Jr. | Director | Jan 29, 2016 | Sale | $41.52 | 627 | 26,033 | 131,713 | Feb 01, 2016, 05:56 PM |
Cantley Lewis Clayton Jr. | Director | Jan 28, 2016 | Sale | $44.33 | 625 | 27,706 | 132,340 | Feb 01, 2016, 05:56 PM |
Cantley Lewis Clayton Jr. | Director | Jan 28, 2016 | Sale | $44.33 | 627 | 27,795 | 132,340 | Feb 01, 2016, 05:56 PM |
Biller Scott | Chief Scientific Officer | Jan 07, 2016 | Option Exercise | $0.47 | 15,000 | 7,013 | 49,070 | Jan 11, 2016, 04:23 PM |
Schenkein David P | Chief Executive Officer | Jan 07, 2016 | Option Exercise | $0.30 | 20,000 | 6,050 | 272,272 | Jan 11, 2016, 04:22 PM |
Biller Scott | Chief Scientific Officer | Dec 31, 2015 | Option Exercise | $31.64 | 5,500 | 174,020 | 39,570 | Jan 05, 2016, 05:21 PM |
Biller Scott | Chief Scientific Officer | Dec 31, 2015 | Sale | $65.27 | 5,500 | 358,985 | 34,070 | Jan 05, 2016, 05:21 PM |
Higgons John Duncan | Chief Operating Officer | Jan 04, 2016 | Option Exercise | $3.32 | 58,999 | 195,925 | 120,834 | Jan 05, 2016, 05:20 PM |
Schenkein David P | Chief Executive Officer | Jan 04, 2016 | Option Exercise | $0.30 | 10,000 | 3,025 | 242,272 | Jan 05, 2016, 05:17 PM |
Schenkein David P | Chief Executive Officer | Jan 05, 2016 | Option Exercise | $0.30 | 10,000 | 3,025 | 252,272 | Jan 05, 2016, 05:17 PM |
Cantley Lewis Clayton Jr. | Director | Dec 29, 2015 | Sale | $66.16 | 2,670 | 176,647 | 132,967 | Dec 29, 2015, 08:20 PM |
Cantley Lewis Clayton Jr. | Director | Dec 28, 2015 | Sale | $63.72 | 2,662 | 169,623 | 135,635 | Dec 29, 2015, 08:20 PM |
Cantley Lewis Clayton Jr. | Director | Dec 28, 2015 | Sale | $63.73 | 2,662 | 169,649 | 135,637 | Dec 29, 2015, 08:20 PM |
Cantley Lewis Clayton Jr. | Director | Dec 29, 2015 | Sale | $66.11 | 2,670 | 176,514 | 132,965 | Dec 29, 2015, 08:20 PM |
Higgons John Duncan | Chief Operating Officer | Dec 15, 2015 | Sale | $50.09 | 20,000 | 1,001,800 | 61,835 | Dec 17, 2015, 04:02 PM |
Biller Scott | Chief Scientific Officer | Nov 30, 2015 | Option Exercise | $31.64 | 5,500 | 174,020 | 39,570 | Dec 02, 2015, 04:11 PM |
Biller Scott | Chief Scientific Officer | Nov 30, 2015 | Sale | $65.99 | 5,500 | 362,945 | 34,070 | Dec 02, 2015, 04:11 PM |
Higgons John Duncan | Chief Operating Officer | Nov 16, 2015 | Option Exercise | $1.09 | 20,000 | 21,764 | 101,835 | Nov 18, 2015, 04:19 PM |
Higgons John Duncan | Chief Operating Officer | Nov 16, 2015 | Sale | $61.51 | 20,000 | 1,230,200 | 81,835 | Nov 18, 2015, 04:19 PM |
Cantley Lewis Clayton Jr. | Director | Nov 17, 2015 | Sale | $59.98 | 3,492 | 209,450 | 138,297 | Nov 18, 2015, 04:15 PM |
Cantley Lewis Clayton Jr. | Director | Nov 17, 2015 | Sale | $59.99 | 3,490 | 209,365 | 138,299 | Nov 18, 2015, 04:15 PM |
Cantley Lewis Clayton Jr. | Director | Nov 16, 2015 | Sale | $59.38 | 1,213 | 72,028 | 141,789 | Nov 18, 2015, 04:15 PM |
Cantley Lewis Clayton Jr. | Director | Nov 16, 2015 | Sale | $59.38 | 1,213 | 72,028 | 141,789 | Nov 18, 2015, 04:15 PM |
Biller Scott | Chief Scientific Officer | Nov 02, 2015 | Option Exercise | $31.64 | 5,500 | 174,020 | 39,570 | Nov 03, 2015, 05:46 PM |
Biller Scott | Chief Scientific Officer | Nov 02, 2015 | Sale | $77.12 | 5,500 | 424,160 | 34,070 | Nov 03, 2015, 05:46 PM |
Schenkein David P | Chief Executive Officer | Oct 27, 2015 | Option Exercise | $31.64 | 4,000 | 126,560 | 236,272 | Oct 30, 2015, 10:52 AM |
Schenkein David P | Chief Executive Officer | Oct 27, 2015 | Sale | $80.26 | 4,000 | 321,040 | 232,272 | Oct 30, 2015, 10:52 AM |
Cantley Lewis Clayton Jr. | Director | Oct 22, 2015 | Sale | $61.21 | 2,426 | 148,495 | 145,428 | Oct 27, 2015, 09:14 AM |
Cantley Lewis Clayton Jr. | Director | Oct 23, 2015 | Sale | $61.10 | 2,426 | 148,229 | 143,002 | Oct 27, 2015, 09:14 AM |
Cantley Lewis Clayton Jr. | Director | Oct 23, 2015 | Sale | $61.11 | 2,426 | 148,253 | 143,002 | Oct 27, 2015, 09:14 AM |
Cantley Lewis Clayton Jr. | Director | Oct 22, 2015 | Sale | $61.22 | 2,426 | 148,520 | 145,428 | Oct 27, 2015, 09:14 AM |
Higgons John Duncan | Chief Operating Officer | Oct 15, 2015 | Option Exercise | $0.31 | 20,000 | 6,244 | 101,835 | Oct 19, 2015, 05:35 PM |
Higgons John Duncan | Chief Operating Officer | Oct 15, 2015 | Sale | $71.04 | 20,000 | 1,420,800 | 81,835 | Oct 19, 2015, 05:35 PM |
Higgons John Duncan | Chief Operating Officer | Sep 30, 2015 | Option Exercise | $0.30 | 10,000 | 3,025 | 151,835 | Oct 02, 2015, 04:11 PM |
Biller Scott | Chief Scientific Officer | Sep 30, 2015 | Option Exercise | $31.64 | 5,500 | 174,020 | 39,570 | Oct 02, 2015, 04:05 PM |
Biller Scott | Chief Scientific Officer | Sep 30, 2015 | Sale | $70.44 | 5,500 | 387,420 | 34,070 | Oct 02, 2015, 04:05 PM |
Goddard Glenn | Senior Vice President, Finance | Sep 24, 2015 | Option Exercise | $88.89 | 4,856 | 431,650 | 5,144 | Sep 28, 2015, 05:15 PM |
Goddard Glenn | Senior Vice President, Finance | Sep 24, 2015 | Option Exercise | $23.10 | 856 | 19,774 | 6,000 | Sep 28, 2015, 05:15 PM |
Goddard Glenn | Senior Vice President, Finance | Sep 24, 2015 | Sale | $85.97 | 6,000 | 515,820 | 0 | Sep 28, 2015, 05:15 PM |
Cantley Lewis Clayton Jr. | Director | Sep 24, 2015 | Sale | $84.43 | 2,426 | 204,827 | 150,280 | Sep 28, 2015, 05:13 PM |
Cantley Lewis Clayton Jr. | Director | Sep 25, 2015 | Sale | $82.07 | 2,426 | 199,102 | 147,854 | Sep 28, 2015, 05:13 PM |
Cantley Lewis Clayton Jr. | Director | Sep 25, 2015 | Sale | $82.09 | 2,426 | 199,150 | 147,854 | Sep 28, 2015, 05:13 PM |
Cantley Lewis Clayton Jr. | Director | Sep 24, 2015 | Sale | $84.42 | 2,426 | 204,803 | 150,280 | Sep 28, 2015, 05:13 PM |
Higgons John Duncan | Chief Operating Officer | Sep 15, 2015 | Option Exercise | $0.30 | 20,000 | 6,050 | 161,835 | Sep 17, 2015, 06:39 PM |
Higgons John Duncan | Chief Operating Officer | Sep 15, 2015 | Sale | $91.11 | 20,000 | 1,822,200 | 141,835 | Sep 17, 2015, 06:39 PM |
Higgons John Duncan | Chief Operating Officer | Aug 20, 2015 | Option Exercise | $0.30 | 10,000 | 3,025 | 141,835 | Aug 21, 2015, 04:56 PM |
Higgons John Duncan | Chief Operating Officer | Aug 17, 2015 | Option Exercise | $0.30 | 20,000 | 6,050 | 151,835 | Aug 19, 2015, 04:11 PM |
Higgons John Duncan | Chief Operating Officer | Aug 17, 2015 | Sale | $92.24 | 20,000 | 1,844,800 | 131,835 | Aug 19, 2015, 04:11 PM |
Cantley Lewis Clayton Jr. | Director | Aug 18, 2015 | Sale | $95.69 | 2,426 | 232,144 | 152,706 | Aug 19, 2015, 04:09 PM |
Cantley Lewis Clayton Jr. | Director | Aug 18, 2015 | Sale | $95.69 | 2,426 | 232,144 | 152,706 | Aug 19, 2015, 04:09 PM |
Cantley Lewis Clayton Jr. | Director | Aug 17, 2015 | Sale | $94.18 | 2,426 | 228,481 | 155,132 | Aug 19, 2015, 04:09 PM |
Cantley Lewis Clayton Jr. | Director | Aug 17, 2015 | Sale | $94.21 | 2,426 | 228,553 | 155,132 | Aug 19, 2015, 04:09 PM |
Biller Scott | Chief Scientific Officer | Aug 10, 2015 | Option Exercise | $31.64 | 5,500 | 174,020 | 39,570 | Aug 12, 2015, 05:02 PM |
Biller Scott | Chief Scientific Officer | Aug 10, 2015 | Sale | $100.00 | 5,500 | 550,000 | 34,070 | Aug 12, 2015, 05:02 PM |
Higgons John Duncan | Chief Operating Officer | Aug 06, 2015 | Option Exercise | $0.30 | 10,000 | 3,025 | 131,835 | Aug 10, 2015, 05:19 PM |
Schenkein David P | Chief Executive Officer | Aug 03, 2015 | Option Exercise | $28.89 | 8,000 | 231,152 | 240,272 | Aug 05, 2015, 05:11 PM |
Schenkein David P | Chief Executive Officer | Aug 03, 2015 | Sale | $110.60 | 8,000 | 884,800 | 232,272 | Aug 05, 2015, 05:11 PM |
Goddard Glenn | Senior Vice President, Finance | Jul 23, 2015 | Option Exercise | $30.03 | 7,000 | 210,216 | 7,000 | Jul 27, 2015, 05:36 PM |
Goddard Glenn | Senior Vice President, Finance | Jul 23, 2015 | Sale | $120.45 | 7,000 | 843,150 | 0 | Jul 27, 2015, 05:36 PM |
Biller Scott | Chief Scientific Officer | Jul 20, 2015 | Option Exercise | $31.64 | 5,500 | 174,020 | 39,570 | Jul 22, 2015, 06:30 PM |
Biller Scott | Chief Scientific Officer | Jul 20, 2015 | Sale | $113.87 | 5,500 | 626,285 | 34,070 | Jul 22, 2015, 06:30 PM |
Goddard Glenn | Senior Vice President, Finance | Jul 17, 2015 | Option Exercise | $5.89 | 13,000 | 76,603 | 13,000 | Jul 21, 2015, 06:41 PM |
Goddard Glenn | Senior Vice President, Finance | Jul 17, 2015 | Sale | $113.71 | 13,000 | 1,478,230 | 0 | Jul 21, 2015, 06:41 PM |
Cantley Lewis Clayton Jr. | Director | Jul 16, 2015 | Sale | $114.17 | 2,426 | 276,976 | 157,558 | Jul 17, 2015, 05:01 PM |
Cantley Lewis Clayton Jr. | Director | Jul 15, 2015 | Sale | $114.35 | 2,426 | 277,413 | 159,984 | Jul 17, 2015, 05:01 PM |
Cantley Lewis Clayton Jr. | Director | Jul 15, 2015 | Sale | $114.38 | 2,426 | 277,486 | 159,984 | Jul 17, 2015, 05:01 PM |
Cantley Lewis Clayton Jr. | Director | Jul 16, 2015 | Sale | $114.20 | 2,426 | 277,049 | 157,558 | Jul 17, 2015, 05:01 PM |
Higgons John Duncan | Chief Operating Officer | Jul 16, 2015 | Option Exercise | $0.30 | 20,000 | 6,050 | 141,835 | Jul 17, 2015, 04:46 PM |
Higgons John Duncan | Chief Operating Officer | Jul 16, 2015 | Sale | $114.02 | 20,000 | 2,280,400 | 121,835 | Jul 17, 2015, 04:46 PM |
Biller Scott | Chief Scientific Officer | May 07, 2015 | Sale | $96.32 | 5,500 | 529,760 | 34,070 | Jul 08, 2015, 04:04 PM |
Biller Scott | Chief Scientific Officer | Apr 08, 2015 | Sale | $97.64 | 5,500 | 537,020 | 39,570 | Jul 08, 2015, 04:04 PM |
Biller Scott | Chief Scientific Officer | Jun 26, 2015 | Option Exercise | $0.47 | 7,500 | 3,506 | 45,070 | Jun 30, 2015, 05:48 PM |
Cantley Lewis Clayton Jr. | Director | Jun 25, 2015 | Sale | $105.66 | 2,426 | 256,331 | 162,410 | Jun 25, 2015, 06:22 PM |
Cantley Lewis Clayton Jr. | Director | Jun 25, 2015 | Sale | $105.66 | 2,426 | 256,331 | 162,410 | Jun 25, 2015, 06:22 PM |
Cantley Lewis Clayton Jr. | Director | Jun 24, 2015 | Sale | $104.59 | 2,426 | 253,735 | 164,836 | Jun 25, 2015, 06:22 PM |
Cantley Lewis Clayton Jr. | Director | Jun 24, 2015 | Sale | $104.60 | 2,426 | 253,760 | 164,836 | Jun 25, 2015, 06:22 PM |
Biller Scott | Chief Scientific Officer | Jun 16, 2015 | Option Exercise | $0.47 | 300 | 140 | 37,570 | Jun 17, 2015, 06:28 PM |
Higgons John Duncan | Chief Operating Officer | Jun 15, 2015 | Sale | $105.23 | 7,000 | 736,610 | 121,835 | Jun 16, 2015, 05:23 PM |
Higgons John Duncan | Chief Operating Officer | Jun 12, 2015 | Option Exercise | $0.30 | 10,000 | 3,025 | 128,835 | Jun 12, 2015, 04:53 PM |
Higgons John Duncan | Chief Operating Officer | Jun 11, 2015 | Option Exercise | $0.30 | 10,000 | 3,025 | 118,835 | Jun 12, 2015, 04:53 PM |
Higgons John Duncan | Chief Operating Officer | Jun 10, 2015 | Option Exercise | $0.30 | 10,000 | 3,025 | 108,835 | Jun 12, 2015, 04:53 PM |
Biller Scott | Chief Scientific Officer | Jun 08, 2015 | Sale | $121.85 | 5,500 | 670,175 | 37,270 | Jun 09, 2015, 05:20 PM |
Schenkein David P | Chief Executive Officer | Jun 01, 2015 | Sale | $120.67 | 13,000 | 1,568,710 | 232,272 | Jun 02, 2015, 06:19 PM |
Bowden Christopher | Chief Medical Officer | Jun 01, 2015 | Option Exercise | $35.16 | 5,000 | 175,800 | 5,000 | Jun 02, 2015, 06:19 PM |
Bowden Christopher | Chief Medical Officer | Jun 01, 2015 | Sale | $120.67 | 5,000 | 603,350 | 0 | Jun 02, 2015, 06:19 PM |
Schenkein David P | Chief Executive Officer | May 27, 2015 | Sale | $120.05 | 8,929 | 1,071,926 | 85,582 | May 28, 2015, 05:34 PM |
Goddard Glenn | Senior Vice President, Finance | May 27, 2015 | Option Exercise | $23.10 | 2,171 | 50,150 | 2,171 | May 28, 2015, 05:30 PM |
Goddard Glenn | Senior Vice President, Finance | May 27, 2015 | Sale | $120.05 | 2,171 | 260,629 | 0 | May 28, 2015, 05:30 PM |
Cantley Lewis Clayton Jr. | Director | May 19, 2015 | Sale | $116.66 | 2,426 | 283,017 | 169,688 | May 21, 2015, 05:12 PM |
Cantley Lewis Clayton Jr. | Director | May 19, 2015 | Sale | $116.69 | 2,426 | 283,090 | 169,688 | May 21, 2015, 05:12 PM |
Cantley Lewis Clayton Jr. | Director | May 20, 2015 | Sale | $116.60 | 2,426 | 282,872 | 167,262 | May 21, 2015, 05:12 PM |
Cantley Lewis Clayton Jr. | Director | May 20, 2015 | Sale | $116.60 | 2,426 | 282,872 | 167,262 | May 21, 2015, 05:12 PM |
Higgons John Duncan | Chief Operating Officer | May 15, 2015 | Sale | $112.89 | 7,417 | 837,305 | 98,835 | May 18, 2015, 07:06 PM |
Schenkein David P | Chief Executive Officer | May 12, 2015 | Sale | $110.03 | 2,093 | 230,293 | 94,701 | May 13, 2015, 04:39 PM |
Schenkein David P | Chief Executive Officer | May 11, 2015 | Sale | $110.01 | 3,107 | 341,801 | 96,794 | May 13, 2015, 04:39 PM |
Schenkein David P | Chief Executive Officer | May 07, 2015 | Option Exercise | $0.30 | 10,000 | 3,025 | 241,372 | May 11, 2015, 05:14 PM |
Schenkein David P | Chief Executive Officer | May 08, 2015 | Sale | $101.32 | 3,900 | 395,148 | 238,772 | May 11, 2015, 05:14 PM |
Schenkein David P | Chief Executive Officer | May 01, 2015 | Sale | $93.63 | 3,900 | 365,157 | 231,372 | May 05, 2015, 04:54 PM |
Cantley Lewis Clayton Jr. | Director | Apr 24, 2015 | Sale | $106.49 | 2,426 | 258,345 | 172,114 | Apr 27, 2015, 05:43 PM |
Cantley Lewis Clayton Jr. | Director | Apr 24, 2015 | Sale | $106.45 | 2,426 | 258,248 | 172,114 | Apr 27, 2015, 05:43 PM |
Cantley Lewis Clayton Jr. | Director | Apr 23, 2015 | Sale | $103.83 | 2,426 | 251,892 | 174,540 | Apr 27, 2015, 05:43 PM |
Cantley Lewis Clayton Jr. | Director | Apr 23, 2015 | Sale | $103.82 | 2,426 | 251,867 | 174,540 | Apr 27, 2015, 05:43 PM |
Higgons John Duncan | Chief Operating Officer | Apr 15, 2015 | Sale | $99.54 | 6,583 | 655,272 | 106,252 | Apr 17, 2015, 05:26 PM |
Schenkein David P | Chief Executive Officer | Apr 13, 2015 | Sale | $100.03 | 3,900 | 390,117 | 235,272 | Apr 15, 2015, 05:04 PM |
Schenkein David P | Chief Executive Officer | Apr 01, 2015 | Sale | $92.54 | 3,900 | 360,906 | 237,872 | Apr 03, 2015, 05:37 PM |
Cantley Lewis Clayton Jr. | Director | Mar 27, 2015 | Sale | $96.33 | 2,426 | 233,697 | 176,966 | Mar 30, 2015, 05:59 PM |
Cantley Lewis Clayton Jr. | Director | Mar 27, 2015 | Sale | $96.35 | 2,426 | 233,745 | 176,966 | Mar 30, 2015, 05:59 PM |
Cantley Lewis Clayton Jr. | Director | Mar 26, 2015 | Sale | $90.81 | 2,426 | 220,305 | 179,392 | Mar 30, 2015, 05:59 PM |
Cantley Lewis Clayton Jr. | Director | Mar 26, 2015 | Sale | $90.84 | 2,426 | 220,378 | 179,392 | Mar 30, 2015, 05:59 PM |
Higgons John Duncan | Chief Operating Officer | Mar 16, 2015 | Sale | $106.24 | 7,000 | 743,680 | 112,835 | Mar 18, 2015, 05:18 PM |
Goddard Glenn | Senior Vice President, Finance | Mar 16, 2015 | Option Exercise | $27.26 | 10,000 | 272,624 | 10,000 | Mar 18, 2015, 05:17 PM |
Goddard Glenn | Senior Vice President, Finance | Mar 16, 2015 | Sale | $106.24 | 10,000 | 1,062,400 | 0 | Mar 18, 2015, 05:17 PM |
Biller Scott | Chief Scientific Officer | Mar 16, 2015 | Option Exercise | $0.47 | 5,500 | 2,571 | 48,270 | Mar 18, 2015, 05:15 PM |
Biller Scott | Chief Scientific Officer | Mar 16, 2015 | Sale | $106.81 | 5,500 | 587,455 | 42,770 | Mar 18, 2015, 05:15 PM |
Schenkein David P | Chief Executive Officer | Mar 05, 2015 | Sale | $110.16 | 2,600 | 286,416 | 102,501 | Mar 09, 2015, 06:41 PM |
Biller Scott | Chief Scientific Officer | Feb 27, 2015 | Option Exercise | $39.35 | 270 | 10,624 | 42,770 | Mar 03, 2015, 05:22 PM |
Schenkein David P | Chief Executive Officer | Feb 27, 2015 | Option Exercise | $0.30 | 25,000 | 7,563 | 248,272 | Mar 03, 2015, 05:18 PM |
Schenkein David P | Chief Executive Officer | Mar 02, 2015 | Sale | $107.05 | 7,800 | 834,990 | 241,772 | Mar 03, 2015, 05:18 PM |
Goddard Glenn | Senior Vice President, Finance | Feb 13, 2015 | Option Exercise | $23.10 | 1,316 | 30,400 | 1,316 | Feb 17, 2015, 05:20 PM |
Goddard Glenn | Senior Vice President, Finance | Feb 13, 2015 | Sale | $120.31 | 1,316 | 158,328 | 0 | Feb 17, 2015, 05:20 PM |
Schenkein David P | Chief Executive Officer | Feb 13, 2015 | Sale | $120.31 | 684 | 82,292 | 106,401 | Feb 13, 2015, 05:39 PM |
Schenkein David P | Chief Executive Officer | Feb 11, 2015 | Sale | $120.14 | 787 | 94,550 | 107,085 | Feb 13, 2015, 05:39 PM |
Goddard Glenn | Senior Vice President, Finance | Feb 11, 2015 | Option Exercise | $23.10 | 1,513 | 34,950 | 1,513 | Feb 11, 2015, 06:22 PM |
Goddard Glenn | Senior Vice President, Finance | Feb 09, 2015 | Option Exercise | $22.08 | 15,000 | 331,237 | 15,000 | Feb 11, 2015, 06:22 PM |
Goddard Glenn | Senior Vice President, Finance | Feb 11, 2015 | Sale | $120.14 | 1,513 | 181,772 | 0 | Feb 11, 2015, 06:22 PM |
Goddard Glenn | Senior Vice President, Finance | Feb 09, 2015 | Sale | $105.81 | 15,000 | 1,587,150 | 0 | Feb 11, 2015, 06:22 PM |
Schenkein David P | Chief Executive Officer | Feb 02, 2015 | Sale | $114.31 | 10,400 | 1,188,824 | 223,272 | Feb 03, 2015, 06:34 PM |
Biller Scott | Chief Scientific Officer | Jan 02, 2015 | Option Exercise | $0.47 | 4,500 | 2,104 | 47,000 | Jan 06, 2015, 05:36 PM |
Biller Scott | Chief Scientific Officer | Jan 02, 2015 | Sale | $110.08 | 4,500 | 495,360 | 42,500 | Jan 06, 2015, 05:36 PM |
Schenkein David P | Chief Executive Officer | Jan 02, 2015 | Sale | $110.08 | 13,000 | 1,431,040 | 229,772 | Jan 06, 2015, 05:26 PM |
Higgons John Duncan | Chief Operating Officer | Jan 02, 2015 | Sale | $110.08 | 12,000 | 1,320,960 | 119,835 | Jan 06, 2015, 05:23 PM |
Higgons John Duncan | Chief Operating Officer | Jan 02, 2015 | Sale | $110.08 | 12,000 | 1,320,960 | 119,835 | Jan 06, 2015, 05:22 PM |
MARAGANORE JOHN | Director | Dec 16, 2014 | Buy | $110.75 | 1,806 | 200,015 | 50,689 | Dec 18, 2014, 05:42 PM |
Celgene European Investment Co LLC | 10% Owner | Dec 16, 2014 | Buy | $110.75 | 228,645 | 25,322,434 | 1,231,778 | Dec 17, 2014, 04:04 PM |
Schenkein David P | Chief Executive Officer | Dec 01, 2014 | Sale | $97.03 | 13,000 | 1,261,390 | 236,272 | Dec 02, 2014, 06:18 PM |
Higgons John Duncan | Chief Operating Officer | Dec 01, 2014 | Sale | $97.03 | 12,000 | 1,164,360 | 131,835 | Dec 02, 2014, 06:16 PM |
Biller Scott | Chief Scientific Officer | Dec 01, 2014 | Option Exercise | $0.47 | 4,500 | 2,104 | 47,000 | Dec 02, 2014, 06:15 PM |
Biller Scott | Chief Scientific Officer | Dec 01, 2014 | Sale | $97.03 | 4,500 | 436,635 | 42,500 | Dec 02, 2014, 06:15 PM |
Biller Scott | Chief Scientific Officer | Nov 20, 2014 | Option Exercise | $0.47 | 7,500 | 3,506 | 42,500 | Nov 24, 2014, 05:47 PM |
Schenkein David P | Chief Executive Officer | Nov 03, 2014 | Sale | $81.71 | 13,000 | 1,062,230 | 242,772 | Nov 04, 2014, 06:18 PM |
Goddard Glenn | Senior Vice President, Finance | Nov 03, 2014 | Option Exercise | $8.10 | 2,000 | 16,193 | 2,000 | Nov 04, 2014, 06:17 PM |
Goddard Glenn | Senior Vice President, Finance | Nov 03, 2014 | Sale | $81.71 | 2,000 | 163,420 | 0 | Nov 04, 2014, 06:17 PM |
Higgons John Duncan | Chief Operating Officer | Nov 03, 2014 | Sale | $81.71 | 13,000 | 1,062,230 | 143,835 | Nov 04, 2014, 06:16 PM |
Biller Scott | Chief Scientific Officer | Nov 03, 2014 | Option Exercise | $0.47 | 4,500 | 2,104 | 39,500 | Nov 04, 2014, 06:14 PM |
Biller Scott | Chief Scientific Officer | Nov 03, 2014 | Sale | $81.71 | 4,500 | 367,695 | 35,000 | Nov 04, 2014, 06:14 PM |
Schenkein David P | Chief Executive Officer | Oct 01, 2014 | Option Exercise | $0.30 | 2,500 | 756 | 255,772 | Oct 03, 2014, 05:06 PM |
Schenkein David P | Chief Executive Officer | Oct 01, 2014 | Sale | $60.07 | 13,000 | 780,910 | 249,272 | Oct 03, 2014, 05:06 PM |
Higgons John Duncan | Chief Operating Officer | Oct 01, 2014 | Sale | $60.07 | 13,000 | 780,910 | 156,835 | Oct 03, 2014, 05:05 PM |
Biller Scott | Chief Scientific Officer | Oct 01, 2014 | Option Exercise | $0.47 | 4,500 | 2,104 | 39,500 | Oct 03, 2014, 05:04 PM |
Biller Scott | Chief Scientific Officer | Oct 01, 2014 | Sale | $60.07 | 4,500 | 270,315 | 35,000 | Oct 03, 2014, 05:04 PM |
Goddard Glenn | Senior Vice President, Finance | Oct 01, 2014 | Option Exercise | $9.05 | 1,500 | 13,575 | 1,500 | Oct 03, 2014, 05:03 PM |
Goddard Glenn | Senior Vice President, Finance | Oct 01, 2014 | Sale | $60.07 | 1,500 | 90,105 | 0 | Oct 03, 2014, 05:03 PM |
Goddard Glenn | Senior Vice President, Finance | Sep 26, 2014 | Option Exercise | $5.21 | 17,500 | 91,222 | 17,500 | Sep 29, 2014, 05:51 PM |
Goddard Glenn | Senior Vice President, Finance | Sep 26, 2014 | Sale | $56.53 | 17,500 | 989,275 | 0 | Sep 29, 2014, 05:51 PM |
Schenkein David P | Chief Executive Officer | Sep 26, 2014 | Option Exercise | $0.30 | 30,000 | 9,075 | 283,272 | Sep 29, 2014, 05:47 PM |
Schenkein David P | Chief Executive Officer | Sep 26, 2014 | Sale | $62.68 | 60,000 | 3,760,800 | 253,272 | Sep 29, 2014, 05:47 PM |
Biller Scott | Chief Scientific Officer | Sep 19, 2014 | Option Exercise | $0.47 | 37,996 | 17,763 | 72,996 | Sep 22, 2014, 05:49 PM |
Biller Scott | Chief Scientific Officer | Sep 19, 2014 | Sale | $50.45 | 37,996 | 1,916,898 | 35,000 | Sep 22, 2014, 05:49 PM |
Biller Scott | Chief Scientific Officer | Aug 07, 2014 | Option Exercise | $0.47 | 5,000 | 2,338 | 35,000 | Sep 03, 2014, 06:18 PM |
Biller Scott | Chief Scientific Officer | Sep 02, 2014 | Option Exercise | $0.47 | 4,500 | 2,104 | 39,500 | Sep 03, 2014, 06:18 PM |
Biller Scott | Chief Scientific Officer | Sep 02, 2014 | Sale | $46.30 | 4,500 | 208,350 | 35,000 | Sep 03, 2014, 06:18 PM |
Goddard Glenn | Senior Vice President, Finance | Sep 02, 2014 | Option Exercise | $2.26 | 10,000 | 22,648 | 10,000 | Sep 03, 2014, 06:17 PM |
Goddard Glenn | Senior Vice President, Finance | Sep 02, 2014 | Sale | $46.30 | 10,000 | 463,000 | 0 | Sep 03, 2014, 06:17 PM |
Schenkein David P | Chief Executive Officer | Sep 02, 2014 | Option Exercise | $0.30 | 6,500 | 1,966 | 259,772 | Sep 03, 2014, 06:17 PM |
Schenkein David P | Chief Executive Officer | Sep 02, 2014 | Sale | $46.30 | 13,000 | 601,900 | 253,272 | Sep 03, 2014, 06:17 PM |
Higgons John Duncan | Chief Operating Officer | Sep 02, 2014 | Option Exercise | $0.30 | 6,745 | 2,040 | 182,835 | Sep 03, 2014, 06:16 PM |
Higgons John Duncan | Chief Operating Officer | Sep 02, 2014 | Sale | $46.30 | 13,000 | 601,900 | 169,835 | Sep 03, 2014, 06:16 PM |
Higgons John Duncan | Chief Operating Officer | Aug 26, 2014 | Option Exercise | $0.30 | 5,000 | 1,513 | 181,090 | Aug 28, 2014, 05:00 PM |
Higgons John Duncan | Chief Operating Officer | Aug 26, 2014 | Sale | $45.05 | 5,000 | 225,250 | 176,090 | Aug 28, 2014, 05:00 PM |
Schenkein David P | Chief Executive Officer | Aug 11, 2014 | Sale | $40.17 | 4,530 | 181,970 | 253,272 | Aug 12, 2014, 06:07 PM |
Schenkein David P | Chief Executive Officer | Aug 01, 2014 | Sale | $39.17 | 8,470 | 331,770 | 255,537 | Aug 05, 2014, 07:06 PM |
Higgons John Duncan | Chief Operating Officer | Aug 01, 2014 | Option Exercise | $0.30 | 7,000 | 2,118 | 183,090 | Aug 05, 2014, 07:03 PM |
Higgons John Duncan | Chief Operating Officer | Aug 01, 2014 | Sale | $39.09 | 7,000 | 273,630 | 176,090 | Aug 05, 2014, 07:03 PM |
Biller Scott | Chief Scientific Officer | Aug 01, 2014 | Option Exercise | $0.47 | 4,500 | 2,104 | 34,500 | Aug 05, 2014, 07:01 PM |
Biller Scott | Chief Scientific Officer | Aug 01, 2014 | Sale | $39.09 | 4,500 | 175,905 | 30,000 | Aug 05, 2014, 07:01 PM |
Schenkein David P | Chief Executive Officer | Jul 01, 2014 | Sale | $46.52 | 13,000 | 604,760 | 259,772 | Jul 02, 2014, 07:12 PM |
Goddard Glenn | Senior Vice President, Finance | Jul 01, 2014 | Option Exercise | $1.11 | 3,500 | 3,893 | 3,500 | Jul 02, 2014, 07:07 PM |
Goddard Glenn | Senior Vice President, Finance | Jul 01, 2014 | Sale | $46.52 | 3,500 | 162,820 | 0 | Jul 02, 2014, 07:07 PM |
Higgons John Duncan | Chief Operating Officer | Jul 01, 2014 | Sale | $46.52 | 12,000 | 558,240 | 176,090 | Jul 02, 2014, 07:06 PM |
Biller Scott | Chief Scientific Officer | Jul 01, 2014 | Option Exercise | $0.47 | 4,500 | 2,104 | 34,500 | Jul 02, 2014, 07:05 PM |
Biller Scott | Chief Scientific Officer | Jul 01, 2014 | Sale | $46.52 | 4,500 | 209,340 | 30,000 | Jul 02, 2014, 07:05 PM |
MARAGANORE JOHN | Director | Jun 23, 2014 | Buy | $43.98 | 2,300 | 101,154 | 48,883 | Jun 24, 2014, 08:20 AM |
Biller Scott | Chief Scientific Officer | Jun 20, 2014 | Option Exercise | $0.47 | 2,004 | 937 | 32,004 | Jun 23, 2014, 05:40 PM |
Biller Scott | Chief Scientific Officer | Jun 20, 2014 | Sale | $50.05 | 2,004 | 100,300 | 30,000 | Jun 23, 2014, 05:40 PM |
Higgons John Duncan | Chief Operating Officer | Jun 13, 2014 | Sale | $45.27 | 5,000 | 226,350 | 188,090 | Jun 16, 2014, 06:01 PM |
Higgons John Duncan | Chief Operating Officer | Jun 03, 2014 | Sale | $35.01 | 3,700 | 129,537 | 193,090 | Jun 04, 2014, 06:44 PM |
Higgons John Duncan | Chief Operating Officer | Jun 02, 2014 | Sale | $33.87 | 3,300 | 111,771 | 196,790 | Jun 04, 2014, 06:44 PM |
Biller Scott | Chief Scientific Officer | Jun 02, 2014 | Option Exercise | $0.47 | 4,500 | 2,104 | 34,500 | Jun 04, 2014, 06:39 PM |
Biller Scott | Chief Scientific Officer | Jun 02, 2014 | Sale | $33.76 | 4,500 | 151,920 | 30,000 | Jun 04, 2014, 06:39 PM |
Higgons John Duncan | Chief Operating Officer | May 06, 2014 | Sale | $45.73 | 5,000 | 228,650 | 200,090 | May 07, 2014, 06:33 PM |
Goddard Glenn | Senior Vice President, Finance | May 01, 2014 | Option Exercise | $1.27 | 2,000 | 2,532 | 2,000 | May 05, 2014, 05:17 PM |
Goddard Glenn | Senior Vice President, Finance | May 01, 2014 | Sale | $42.39 | 2,000 | 84,780 | 0 | May 05, 2014, 05:17 PM |
Higgons John Duncan | Chief Operating Officer | May 01, 2014 | Option Exercise | $0.30 | 3,000 | 908 | 212,090 | May 05, 2014, 05:16 PM |
Higgons John Duncan | Chief Operating Officer | May 01, 2014 | Sale | $42.39 | 7,000 | 296,730 | 205,090 | May 05, 2014, 05:16 PM |
Biller Scott | Chief Scientific Officer | May 01, 2014 | Option Exercise | $0.47 | 13,500 | 6,311 | 34,500 | May 05, 2014, 05:16 PM |
Biller Scott | Chief Scientific Officer | May 01, 2014 | Sale | $42.39 | 13,500 | 572,265 | 30,000 | May 05, 2014, 05:16 PM |
MARAGANORE JOHN | Director | Apr 29, 2014 | Buy | $44.00 | 2,250 | 99,000 | 46,583 | Apr 30, 2014, 06:11 PM |
Celgene European Investment Co LLC | 10% Owner | Apr 29, 2014 | Buy | $44.00 | 294,800 | 12,971,200 | 1,003,133 | Apr 30, 2014, 04:01 PM |
Higgons John Duncan | Chief Operating Officer | Apr 07, 2014 | Option Exercise | $0.30 | 3,000 | 908 | 212,090 | Apr 08, 2014, 07:35 PM |
Higgons John Duncan | Chief Operating Officer | Apr 07, 2014 | Sale | $45.17 | 3,000 | 135,510 | 209,090 | Apr 08, 2014, 07:35 PM |
Goddard Glenn | Senior Vice President, Finance | Apr 07, 2014 | Option Exercise | $1.16 | 2,000 | 2,315 | 2,000 | Apr 08, 2014, 07:32 PM |
Goddard Glenn | Senior Vice President, Finance | Apr 07, 2014 | Sale | $45.17 | 2,000 | 90,340 | 0 | Apr 08, 2014, 07:32 PM |
Goddard Glenn | Senior Vice President, Finance | Apr 01, 2014 | Option Exercise | $0.64 | 4,000 | 2,542 | 4,000 | Apr 03, 2014, 05:47 PM |
Goddard Glenn | Senior Vice President, Finance | Apr 01, 2014 | Sale | $38.08 | 4,000 | 152,320 | 0 | Apr 03, 2014, 05:47 PM |
Higgons John Duncan | Chief Operating Officer | Apr 01, 2014 | Option Exercise | $0.30 | 12,000 | 3,630 | 221,090 | Apr 03, 2014, 05:46 PM |
Higgons John Duncan | Chief Operating Officer | Apr 01, 2014 | Sale | $38.08 | 12,000 | 456,960 | 209,090 | Apr 03, 2014, 05:46 PM |
Biller Scott | Chief Scientific Officer | Apr 01, 2014 | Option Exercise | $0.47 | 34,500 | 16,129 | 34,500 | Apr 03, 2014, 05:44 PM |
Biller Scott | Chief Scientific Officer | Apr 01, 2014 | Sale | $38.08 | 4,500 | 171,360 | 30,000 | Apr 03, 2014, 05:44 PM |
Tessier-Lavigne Marc | Director | Jul 24, 2013 | Buy | $18.00 | 55,555 | 999,990 | 101,009 | Apr 03, 2014, 05:43 PM |
MARAGANORE JOHN | Director | Jul 24, 2013 | Buy | $18.00 | 8,333 | 149,994 | 44,333 | Apr 03, 2014, 05:41 PM |
Schenkein David P | Chief Executive Officer | Mar 25, 2014 | Option Exercise | $0.30 | 25,000 | 7,563 | 266,272 | Mar 27, 2014, 06:09 PM |
Higgons John Duncan | Chief Operating Officer | Mar 19, 2014 | Option Exercise | $0.30 | 80,000 | 24,200 | 209,090 | Mar 20, 2014, 06:06 PM |
Schenkein David P | Chief Executive Officer | Mar 10, 2014 | Option Exercise | $0.30 | 54,000 | 16,335 | 241,272 | Mar 12, 2014, 06:19 PM |
Higgons John Duncan | Chief Operating Officer | Mar 10, 2014 | Option Exercise | $0.30 | 20,000 | 6,050 | 129,090 | Mar 12, 2014, 06:16 PM |
Goddard Glenn | Senior Vice President, Finance | Mar 07, 2014 | Option Exercise | $0.51 | 12,000 | 6,123 | 12,000 | Mar 07, 2014, 06:20 PM |
Goddard Glenn | Senior Vice President, Finance | Mar 06, 2014 | Option Exercise | $0.47 | 5,468 | 2,556 | 5,468 | Mar 07, 2014, 06:20 PM |
Goddard Glenn | Senior Vice President, Finance | Mar 07, 2014 | Sale | $45.10 | 12,000 | 541,200 | 0 | Mar 07, 2014, 06:20 PM |
Goddard Glenn | Senior Vice President, Finance | Mar 06, 2014 | Sale | $35.54 | 5,468 | 194,333 | 0 | Mar 07, 2014, 06:20 PM |
Higgons John Duncan | Chief Operating Officer | Mar 07, 2014 | Option Exercise | $0.30 | 9,000 | 2,723 | 118,090 | Mar 07, 2014, 05:53 PM |
Higgons John Duncan | Chief Operating Officer | Mar 06, 2014 | Option Exercise | $0.30 | 5,646 | 1,708 | 114,736 | Mar 07, 2014, 05:53 PM |
Higgons John Duncan | Chief Operating Officer | Mar 06, 2014 | Sale | $35.54 | 5,646 | 200,659 | 109,090 | Mar 07, 2014, 05:53 PM |
Higgons John Duncan | Chief Operating Officer | Mar 07, 2014 | Sale | $45.10 | 9,000 | 405,900 | 109,090 | Mar 07, 2014, 05:53 PM |
Higgons John Duncan | Chief Operating Officer | Mar 03, 2014 | Option Exercise | $0.30 | 8,000 | 2,420 | 117,090 | Mar 04, 2014, 05:42 PM |
Higgons John Duncan | Chief Operating Officer | Mar 03, 2014 | Sale | $29.85 | 8,000 | 238,832 | 109,090 | Mar 04, 2014, 05:42 PM |
Biller Scott | Chief Scientific Officer | Mar 03, 2014 | Option Exercise | $0.47 | 6,000 | 2,805 | 6,000 | Mar 04, 2014, 05:40 PM |
Biller Scott | Chief Scientific Officer | Mar 03, 2014 | Sale | $29.85 | 6,000 | 179,124 | 0 | Mar 04, 2014, 05:40 PM |
Goddard Glenn | Senior Vice President, Finance | Feb 18, 2014 | Option Exercise | $0.47 | 3,532 | 1,651 | 3,532 | Feb 20, 2014, 06:46 PM |
Goddard Glenn | Senior Vice President, Finance | Feb 18, 2014 | Sale | $35.06 | 3,532 | 123,832 | 0 | Feb 20, 2014, 06:46 PM |
Higgons John Duncan | Chief Operating Officer | Feb 18, 2014 | Option Exercise | $0.30 | 2,354 | 712 | 111,444 | Feb 20, 2014, 05:58 PM |
Higgons John Duncan | Chief Operating Officer | Feb 18, 2014 | Sale | $35.06 | 2,354 | 82,531 | 109,090 | Feb 20, 2014, 05:58 PM |
Goddard Glenn | Senior Vice President, Finance | Feb 10, 2014 | Option Exercise | $0.47 | 6,000 | 2,805 | 6,000 | Feb 11, 2014, 06:09 PM |
Goddard Glenn | Senior Vice President, Finance | Feb 10, 2014 | Sale | $30.44 | 6,000 | 182,640 | 0 | Feb 11, 2014, 06:09 PM |
Higgons John Duncan | Chief Operating Officer | Feb 03, 2014 | Option Exercise | $0.30 | 8,000 | 2,420 | 117,090 | Feb 04, 2014, 08:56 PM |
Higgons John Duncan | Chief Operating Officer | Feb 03, 2014 | Sale | $25.97 | 8,000 | 207,728 | 109,090 | Feb 04, 2014, 08:56 PM |
Biller Scott | Chief Scientific Officer | Feb 03, 2014 | Option Exercise | $0.47 | 6,000 | 2,805 | 6,000 | Feb 04, 2014, 08:54 PM |
Biller Scott | Chief Scientific Officer | Feb 03, 2014 | Sale | $25.97 | 6,000 | 155,796 | 0 | Feb 04, 2014, 08:54 PM |
Goddard Glenn | Senior Vice President, Finance | Jan 27, 2014 | Option Exercise | $0.47 | 7,000 | 3,273 | 7,000 | Jan 28, 2014, 05:07 PM |
Goddard Glenn | Senior Vice President, Finance | Jan 27, 2014 | Sale | $26.29 | 7,000 | 184,051 | 0 | Jan 28, 2014, 05:07 PM |
Biller Scott | Chief Scientific Officer | Jan 21, 2014 | Option Exercise | $0.47 | 6,000 | 2,805 | 6,000 | Jan 23, 2014, 06:04 PM |
Biller Scott | Chief Scientific Officer | Jan 21, 2014 | Sale | $34.71 | 6,000 | 208,265 | 0 | Jan 23, 2014, 06:04 PM |
Higgons John Duncan | Chief Operating Officer | Jan 21, 2014 | Option Exercise | $0.30 | 12,000 | 3,630 | 121,090 | Jan 23, 2014, 06:02 PM |
Higgons John Duncan | Chief Operating Officer | Jan 21, 2014 | Sale | $34.71 | 12,000 | 416,530 | 109,090 | Jan 23, 2014, 06:02 PM |
Goddard Glenn | Senior Vice President, Finance | Jan 21, 2014 | Option Exercise | $0.47 | 10,000 | 4,675 | 10,000 | Jan 22, 2014, 06:30 PM |
Goddard Glenn | Senior Vice President, Finance | Jan 21, 2014 | Sale | $34.71 | 10,000 | 347,108 | 0 | Jan 22, 2014, 06:30 PM |
Celgene European Investment Co LLC | 10% Owner | Jul 29, 2013 | Buy | $18.00 | 708,333 | 12,749,994 | 708,333 | Jul 30, 2013, 11:58 AM |
Owner | Relationship | Date | Value($) |
FOUSE JACQUALYN A | Director | 04/10/2024 | 214,642 |
Foster-Cheek Kaye I | Director | 03/07/2024 | 40,632 |
Foster-Cheek Kaye I | Director | 03/06/2024 | 141,236 |
Foster-Cheek Kaye I | Director | 03/05/2024 | 9,663 |
Washburn Theodore James Jr. | Principal Accounting Officer | 03/05/2024 | 60,738 |
Burns James William | Chief Legal Officer | 03/05/2024 | 86,050 |
Schenkein David P | Director | 02/27/2024 | 2,193,570 |
Schenkein David P | Director | 02/27/2024 | 2,403,592 |
Schenkein David P | Director | 02/26/2024 | 645,804 |
Schenkein David P | Director | 02/23/2024 | 1,510,209 |
Schenkein David P | Director | 02/26/2024 | 677,441 |
Schenkein David P | Director | 02/23/2024 | 1,577,510 |
Washburn Theodore James Jr. | Principal Accounting Officer | 02/20/2024 | 13,422 |
Gheuens Sarah | Chief Medical Officer | 02/14/2024 | 16,140 |
Burns James William | Chief Legal Officer | 02/14/2024 | 13,701 |
Washburn Theodore James Jr. | Principal Accounting Officer | 02/14/2024 | 6,863 |
Burns James William | Chief Legal Officer | 01/24/2024 | 36,961 |
Gheuens Sarah | Chief Medical Officer | 01/24/2024 | 36,961 |
Jones Cecilia | Chief Financial Officer | 01/24/2024 | 40,813 |
FOUSE JACQUALYN A | Director | 01/24/2024 | 232,024 |
Goff Brian | Chief Executive Officer | 01/24/2024 | 165,221 |
Milanova Tsveta | Chief Commercial Officer | 01/24/2024 | 35,014 |
Goff Brian | Chief Executive Officer | 01/09/2024 | 277,397 |
FOUSE JACQUALYN A | Director | 01/09/2024 | 192,909 |
Burns James William | Chief Legal Officer | 01/09/2024 | 26,737 |
Gheuens Sarah | Chief Medical Officer | 01/09/2024 | 41,129 |
Milanova Tsveta | Chief Commercial Officer | 01/05/2024 | 64,773 |
Jones Cecilia | Chief Financial Officer | 09/28/2023 | 54,017 |
Burns James William | Chief Legal Officer | 08/17/2023 | 168,061 |
Foster-Cheek Kaye I | Director | 08/09/2023 | 452,250 |
Foster-Cheek Kaye I | Director | 08/09/2023 | 648,887 |
Goff Brian | Chief Executive Officer | 08/08/2023 | 259,335 |
Washburn Theodore James Jr. | Principal Accounting Officer | 08/07/2023 | 74,096 |
Washburn Theodore James Jr. | Principal Accounting Officer | 08/01/2023 | 32,352 |
Burns James William | Chief Legal Officer | 06/30/2023 | 48,411 |
FOUSE JACQUALYN A | Director | 06/30/2023 | 303,962 |
Gheuens Sarah | Chief Medical Officer | 06/30/2023 | 48,411 |
Goff Brian | Chief Executive Officer | 06/30/2023 | 324,694 |
Jones Cecilia | Chief Financial Officer | 06/30/2023 | 45,291 |
Milanova Tsveta | Chief Commercial Officer | 06/30/2023 | 45,886 |
FOUSE JACQUALYN A | Director | 04/12/2023 | 101,007 |
Schenkein David P | Director | 04/03/2023 | 148,085 |
Schenkein David P | Director | 04/03/2023 | 373,895 |
Schenkein David P | Director | 03/27/2023 | 181,000 |
Schenkein David P | Director | 03/27/2023 | 443,000 |
Schenkein David P | Director | 03/13/2023 | 181,000 |
Schenkein David P | Director | 03/13/2023 | 449,817 |
Washburn Theodore James Jr. | Principal Accounting Officer | 03/03/2023 | 12,242 |
Gheuens Sarah | Chief Medical Officer | 03/03/2023 | 28,373 |
Washburn Theodore James Jr. | Principal Accounting Officer | 02/14/2023 | 3,672 |
Washburn Theodore James Jr. | Principal Accounting Officer | 02/14/2023 | 14,409 |
Burns James William | Chief Legal Officer | 02/16/2023 | 17,606 |
FOUSE JACQUALYN A | Director | 02/16/2023 | 105,464 |
Schenkein David P | Director | 02/13/2023 | 181,000 |
Schenkein David P | Director | 02/13/2023 | 572,400 |
Burns James William | Chief Legal Officer | 02/14/2023 | 18,287 |
Washburn Theodore James Jr. | Principal Accounting Officer | 02/14/2023 | 7,764 |
Schenkein David P | Director | 01/30/2023 | 181,000 |
Schenkein David P | Director | 01/30/2023 | 586,578 |
Schenkein David P | Director | 01/17/2023 | 181,000 |
Schenkein David P | Director | 01/17/2023 | 577,093 |
Burns James William | Chief Legal Officer | 12/28/2022 | 73,963 |
Gheuens Sarah | Chief Medical Officer | 12/28/2022 | 79,260 |
Gheuens Sarah | Chief Medical Officer | 12/06/2022 | 7,150 |
Poddar Richa | Chief Commercial Officer | 10/17/2022 | 40,808 |
Washburn Theodore James Jr. | Principal Accounting Officer | 02/25/2022 | 3,240 |
Gheuens Sarah | Chief Medical Officer | 02/22/2022 | 27,771 |
Poddar Richa | Chief Commercial Officer | 02/22/2022 | 21,577 |
Car Bruce | Chief Scientific Officer | 02/22/2022 | 59,352 |
Biller Jonathan | Chief Financial Officer | 02/22/2022 | 78,167 |
FOUSE JACQUALYN A | Chief Executive Officer | 02/22/2022 | 106,840 |
Burns James William | Chief Legal Officer | 02/22/2022 | 6,252 |
Schenkein David P | Director | 02/22/2022 | 22,043 |
Washburn Theodore James Jr. | Principal Accounting Officer | 02/22/2022 | 1,716 |
Washburn Theodore James Jr. | Principal Accounting Officer | 02/16/2022 | 7,179 |
FOUSE JACQUALYN A | Chief Executive Officer | 02/14/2022 | 106,903 |
Burns James William | Chief Legal Officer | 02/14/2022 | 65,728 |
Poddar Richa | Chief Commercial Officer | 02/14/2022 | 17,995 |
Washburn Theodore James Jr. | Principal Accounting Officer | 02/14/2022 | 3,874 |
Washburn Theodore James Jr. | Principal Accounting Officer | 02/14/2022 | 15,750 |
Gheuens Sarah | Chief Medical Officer | 02/10/2022 | 23,820 |
Washburn Theodore James Jr. | Principal Accounting Officer | 02/10/2022 | 8,579 |
Biller Jonathan | Chief Financial Officer | 02/10/2022 | 42,392 |
Burns James William | Chief Legal Officer | 02/10/2022 | 20,206 |
Poddar Richa | Chief Commercial Officer | 02/10/2022 | 22,783 |
Car Bruce | Chief Scientific Officer | 01/06/2022 | 39,259 |
Gheuens Sarah | Chief Medical Officer | 12/02/2021 | 8,680 |
Biller Jonathan | Chief Financial Officer | 12/03/2021 | 65,406 |
Alenson Carman | Principal Accounting Officer | 06/21/2021 | 91,533 |
Alenson Carman | Principal Accounting Officer | 06/21/2021 | 109,481 |
Bowden Christopher | Chief Medical Officer | 06/18/2021 | 2,423,991 |
Bowden Christopher | Chief Medical Officer | 06/18/2021 | 2,914,851 |
Miles Darrin | Chief Commercial Officer | 05/14/2021 | 191,829 |
Bowden Christopher | Chief Medical Officer | 04/20/2021 | 515,024 |
Bowden Christopher | Chief Medical Officer | 04/19/2021 | 112,864 |
Bowden Christopher | Chief Medical Officer | 04/20/2021 | 793,581 |
Bowden Christopher | Chief Medical Officer | 04/19/2021 | 177,055 |
Miles Darrin | Chief Commercial Officer | 03/05/2021 | 24,290 |
Miles Darrin | Chief Commercial Officer | 03/01/2021 | 105,578 |
Biller Jonathan | Chief Financial Officer | 12/03/2020 | 78,300 |
Alenson Carman | Principal Accounting Officer | 09/02/2020 | 9,983 |
Bowden Christopher | Chief Medical Officer | 05/20/2020 | 125,978 |
Bowden Christopher | Chief Medical Officer | 05/20/2020 | 179,200 |
Hirsch Andrew | Chief Financial Officer | 04/22/2020 | 88,469 |
Biller Jonathan | Chief Legal Officer | 04/14/2020 | 102,779 |
Hirsch Andrew | Chief Financial Officer | 04/14/2020 | 64,983 |
FOUSE JACQUALYN A | Chief Executive Officer | 04/14/2020 | 149,271 |
Car Bruce | Chief Scientific Officer | 04/14/2020 | 82,377 |
Bowden Christopher | Chief Medical Officer | 04/14/2020 | 96,236 |
Alenson Carman | Principal Accounting Officer | 03/02/2020 | 16,318 |
Alenson Carman | Principal Accounting Officer | 02/26/2020 | 22,241 |
Hirsch Andrew | Chief Financial Officer | 02/24/2020 | 51,385 |
Bowden Christopher | Chief Medical Officer | 02/24/2020 | 77,661 |
Schenkein David P | Director | 02/24/2020 | 42,821 |
Alenson Carman | Principal Accounting Officer | 02/24/2020 | 10,657 |
Alenson Carman | Principal Accounting Officer | 02/20/2020 | 129,529 |
Alenson Carman | Principal Accounting Officer | 02/18/2020 | 60,488 |
Bowden Christopher | Chief Medical Officer | 02/18/2020 | 42,596 |
Hirsch Andrew | Chief Financial Officer | 02/18/2020 | 46,081 |
Schenkein David P | Director | 02/18/2020 | 131,793 |
Bowden Christopher | Chief Medical Officer | 02/11/2020 | 21,834 |
Bowden Christopher | Chief Medical Officer | 02/11/2020 | 31,063 |
Bowden Christopher | Chief Medical Officer | 02/04/2020 | 299,774 |
Bowden Christopher | Chief Medical Officer | 02/05/2020 | 1,246,317 |
Bowden Christopher | Chief Medical Officer | 02/04/2020 | 2,485,989 |
Alenson Carman | Principal Accounting Officer | 12/26/2019 | 147,766 |
FOUSE JACQUALYN A | Chief Executive Officer | 11/13/2019 | 1,249,982 |
Schenkein David P | Director | 11/13/2019 | 249,984 |
CELGENE CORP /DE/ | 10% Owner | 11/12/2019 | 12,499,975 |
Biller Scott | Chief Scientific Officer | 06/11/2019 | 16,872 |
Biller Scott | Chief Scientific Officer | 04/05/2019 | 119,280 |
Biller Scott | Chief Scientific Officer | 04/05/2019 | 203,135 |
Bowden Christopher | Chief Medical Officer | 04/01/2019 | 351,600 |
Bowden Christopher | Chief Medical Officer | 04/01/2019 | 665,747 |
Bowden Christopher | Chief Medical Officer | 03/15/2019 | 351,600 |
Bowden Christopher | Chief Medical Officer | 03/15/2019 | 641,615 |
Biller Scott | Chief Scientific Officer | 03/05/2019 | 115,805 |
Biller Scott | Chief Scientific Officer | 03/05/2019 | 203,032 |
Hoerter Steven L. | Chief Commercial Officer | 03/04/2019 | 198,800 |
Hoerter Steven L. | Chief Commercial Officer | 03/01/2019 | 198,800 |
Hoerter Steven L. | Chief Commercial Officer | 03/04/2019 | 340,000 |
Hoerter Steven L. | Chief Commercial Officer | 03/01/2019 | 330,050 |
Biller Scott | Chief Scientific Officer | 02/27/2019 | 135,875 |
Biller Scott | Chief Scientific Officer | 02/27/2019 | 585,000 |
Alenson Carman | Principal Accounting Officer | 02/21/2019 | 57,231 |
Schenkein David P | Director | 02/19/2019 | 143,392 |
Hoerter Steven L. | Chief Commercial Officer | 02/19/2019 | 60,351 |
Hirsch Andrew | Chief Financial Officer | 02/19/2019 | 47,643 |
Bowden Christopher | Chief Medical Officer | 02/19/2019 | 47,469 |
Biller Scott | Chief Scientific Officer | 02/19/2019 | 50,834 |
Alenson Carman | Principal Accounting Officer | 02/19/2019 | 16,132 |
Alenson Carman | Principal Accounting Officer | 09/28/2018 | 11,620 |
Hirsch Andrew | Chief Financial Officer | 01/22/2019 | 240,595 |
Hoerter Steven L. | Chief Commercial Officer | 01/22/2019 | 304,719 |
Bowden Christopher | Chief Medical Officer | 01/22/2019 | 103,527 |
Biller Scott | Chief Scientific Officer | 12/21/2018 | 47,919 |
Biller Scott | Chief Scientific Officer | 11/05/2018 | 27,150 |
Biller Scott | Chief Scientific Officer | 11/05/2018 | 209,071 |
Biller Scott | Chief Scientific Officer | 10/05/2018 | 27,150 |
Biller Scott | Chief Scientific Officer | 10/05/2018 | 209,377 |
MARAGANORE JOHN | Director | 09/12/2018 | 1,015,982 |
MARAGANORE JOHN | Director | 09/11/2018 | 986,129 |
Schenkein David P | Chief Executive Officer | 09/10/2018 | 276,217 |
Schenkein David P | Chief Executive Officer | 09/05/2018 | 249,028 |
Alenson Carman | Principal Accounting Officer | 09/05/2018 | 16,314 |
Alenson Carman | Principal Accounting Officer | 09/05/2018 | 25,896 |
Biller Scott | Chief Scientific Officer | 09/05/2018 | 27,150 |
Biller Scott | Chief Scientific Officer | 09/05/2018 | 249,215 |
Bowden Christopher | Chief Medical Officer | 08/30/2018 | 59,772 |
Bowden Christopher | Chief Medical Officer | 08/29/2018 | 10,548 |
Bowden Christopher | Chief Medical Officer | 08/30/2018 | 136,051 |
Bowden Christopher | Chief Medical Officer | 08/29/2018 | 24,000 |
Hoerter Steven L. | Chief Commercial Officer | 08/24/2018 | 81,508 |
Hoerter Steven L. | Chief Commercial Officer | 08/24/2018 | 153,586 |
Biller Scott | Chief Scientific Officer | 08/06/2018 | 27,150 |
Biller Scott | Chief Scientific Officer | 08/06/2018 | 240,333 |
Hoerter Steven L. | Chief Commercial Officer | 07/25/2018 | 81,508 |
Hoerter Steven L. | Chief Commercial Officer | 07/25/2018 | 173,389 |
Bowden Christopher | Chief Medical Officer | 07/10/2018 | 70,320 |
Bowden Christopher | Chief Medical Officer | 07/10/2018 | 173,512 |
Alenson Carman | Principal Accounting Officer | 07/09/2018 | 14,223 |
Alenson Carman | Principal Accounting Officer | 07/09/2018 | 23,104 |
Biller Scott | Chief Scientific Officer | 07/05/2018 | 27,150 |
Biller Scott | Chief Scientific Officer | 07/05/2018 | 250,503 |
Hoerter Steven L. | Chief Commercial Officer | 06/22/2018 | 81,508 |
Hoerter Steven L. | Chief Commercial Officer | 06/22/2018 | 200,039 |
Foster-Cheek Kaye I | Director | 06/14/2018 | 456,570 |
Foster-Cheek Kaye I | Director | 06/14/2018 | 841,926 |
Bowden Christopher | Chief Medical Officer | 06/12/2018 | 70,320 |
Bowden Christopher | Chief Medical Officer | 06/12/2018 | 185,786 |
Biller Scott | Chief Scientific Officer | 06/05/2018 | 27,150 |
Biller Scott | Chief Scientific Officer | 06/05/2018 | 280,101 |
Schenkein David P | Chief Executive Officer | 06/01/2018 | 6,280 |
Schenkein David P | Chief Executive Officer | 06/01/2018 | 1,239,608 |
Schenkein David P | Chief Executive Officer | 05/30/2018 | 17,675 |
Schenkein David P | Chief Executive Officer | 05/30/2018 | 4,109,534 |
Schenkein David P | Chief Executive Officer | 05/23/2018 | 14,936 |
Schenkein David P | Chief Executive Officer | 05/23/2018 | 4,463,524 |
Hoerter Steven L. | Chief Commercial Officer | 05/23/2018 | 81,508 |
Hoerter Steven L. | Chief Commercial Officer | 05/23/2018 | 175,808 |
Biller Scott | Chief Scientific Officer | 05/23/2018 | 480,200 |
Biller Scott | Chief Scientific Officer | 05/23/2018 | 1,365,930 |
Bowden Christopher | Chief Medical Officer | 05/11/2018 | 70,320 |
Bowden Christopher | Chief Medical Officer | 05/11/2018 | 170,003 |
Bowden Christopher | Chief Medical Officer | 05/08/2018 | 70,320 |
Bowden Christopher | Chief Medical Officer | 05/08/2018 | 162,760 |
Biller Scott | Chief Scientific Officer | 05/07/2018 | 27,150 |
Biller Scott | Chief Scientific Officer | 05/07/2018 | 245,430 |
Schenkein David P | Chief Executive Officer | 05/01/2018 | 3,933 |
Schenkein David P | Chief Executive Officer | 05/01/2018 | 1,079,500 |
Hoerter Steven L. | Chief Commercial Officer | 04/23/2018 | 81,508 |
Hoerter Steven L. | Chief Commercial Officer | 04/23/2018 | 176,197 |
Bowden Christopher | Chief Medical Officer | 04/12/2018 | 70,320 |
Bowden Christopher | Chief Medical Officer | 04/12/2018 | 170,190 |
Biller Scott | Chief Scientific Officer | 04/05/2018 | 27,150 |
Biller Scott | Chief Scientific Officer | 04/05/2018 | 225,607 |
Schenkein David P | Chief Executive Officer | 04/02/2018 | 3,933 |
Schenkein David P | Chief Executive Officer | 04/02/2018 | 1,010,357 |
Biller Scott | Chief Scientific Officer | 03/28/2018 | 9,611 |
Hoerter Steven L. | Chief Commercial Officer | 03/22/2018 | 81,508 |
Hoerter Steven L. | Chief Commercial Officer | 03/22/2018 | 173,533 |
Foster-Cheek Kaye I | Director | 03/19/2018 | 321,844 |
Foster-Cheek Kaye I | Director | 03/19/2018 | 557,396 |
Scadden David | Director | 03/16/2018 | 16,688 |
Bowden Christopher | Chief Medical Officer | 03/14/2018 | 70,320 |
Bowden Christopher | Chief Medical Officer | 03/14/2018 | 164,661 |
Biller Scott | Chief Scientific Officer | 03/05/2018 | 27,150 |
Biller Scott | Chief Scientific Officer | 03/05/2018 | 249,229 |
Schenkein David P | Chief Executive Officer | 03/01/2018 | 3,933 |
Schenkein David P | Chief Executive Officer | 03/01/2018 | 1,054,218 |
Foster-Cheek Kaye I | Director | 02/26/2018 | 104,126 |
Hoerter Steven L. | Chief Commercial Officer | 02/22/2018 | 81,508 |
Hoerter Steven L. | Chief Commercial Officer | 02/22/2018 | 161,191 |
Bowden Christopher | Chief Medical Officer | 02/16/2018 | 70,320 |
Bowden Christopher | Chief Medical Officer | 02/16/2018 | 155,305 |
Biller Scott | Chief Scientific Officer | 02/05/2018 | 26,601 |
Biller Scott | Chief Scientific Officer | 02/05/2018 | 228,128 |
Bowden Christopher | Chief Medical Officer | 02/01/2018 | 70,320 |
Bowden Christopher | Chief Medical Officer | 02/01/2018 | 157,500 |
Schenkein David P | Chief Executive Officer | 02/01/2018 | 3,933 |
Schenkein David P | Chief Executive Officer | 02/01/2018 | 1,023,756 |
CELGENE CORP /DE/ | 10% Owner | 01/23/2018 | 57,027,318 |
Schenkein David P | Chief Executive Officer | 01/26/2018 | 7,131 |
Schenkein David P | Chief Executive Officer | 01/26/2018 | 1,911,494 |
Alenson Carman | Principal Accounting Officer | 01/12/2018 | 112,424 |
Alenson Carman | Principal Accounting Officer | 01/12/2018 | 161,250 |
Schenkein David P | Chief Executive Officer | 01/24/2018 | 6 |
Schenkein David P | Chief Executive Officer | 01/24/2018 | 1,600 |
Hoerter Steven L. | Chief Commercial Officer | 01/23/2018 | 994,000 |
Hoerter Steven L. | Chief Commercial Officer | 01/23/2018 | 1,870,750 |
Schenkein David P | Chief Executive Officer | 01/24/2018 | 4,094 |
Schenkein David P | Chief Executive Officer | 01/23/2018 | 9,945 |
Schenkein David P | Chief Executive Officer | 01/24/2018 | 1,082,775 |
Schenkein David P | Chief Executive Officer | 01/23/2018 | 2,630,329 |
CELGENE CORP /DE/ | 10% Owner | 01/23/2018 | 57,027,318 |
Schenkein David P | Chief Executive Officer | 01/16/2018 | 16,033 |
Schenkein David P | Chief Executive Officer | 01/16/2018 | 3,877,218 |
Biller Scott | Chief Scientific Officer | 01/10/2018 | 1,403 |
Biller Scott | Chief Scientific Officer | 01/10/2018 | 195,000 |
Cantley Lewis Clayton Jr. | Director | 12/07/2017 | 55,332 |
Cantley Lewis Clayton Jr. | Director | 12/07/2017 | 55,332 |
Cantley Lewis Clayton Jr. | Director | 12/06/2017 | 58,597 |
Cantley Lewis Clayton Jr. | Director | 12/06/2017 | 58,596 |
Biller Scott | Chief Scientific Officer | 12/06/2017 | 81,376 |
Schenkein David P | Chief Executive Officer | 12/01/2017 | 1,815 |
Schenkein David P | Chief Executive Officer | 12/01/2017 | 369,288 |
Biller Scott | Chief Scientific Officer | 12/01/2017 | 67,899 |
Biller Scott | Chief Scientific Officer | 12/01/2017 | 130,459 |
Cantley Lewis Clayton Jr. | Director | 11/13/2017 | 62,070 |
Cantley Lewis Clayton Jr. | Director | 11/14/2017 | 59,700 |
Cantley Lewis Clayton Jr. | Director | 11/14/2017 | 59,700 |
Cantley Lewis Clayton Jr. | Director | 11/13/2017 | 62,070 |
Biller Scott | Chief Scientific Officer | 11/01/2017 | 67,899 |
Biller Scott | Chief Scientific Officer | 11/01/2017 | 134,522 |
Schenkein David P | Chief Executive Officer | 11/01/2017 | 1,815 |
Schenkein David P | Chief Executive Officer | 11/01/2017 | 383,105 |
Cantley Lewis Clayton Jr. | Director | 10/16/2017 | 71,090 |
Cantley Lewis Clayton Jr. | Director | 10/17/2017 | 71,100 |
Cantley Lewis Clayton Jr. | Director | 10/17/2017 | 71,100 |
Cantley Lewis Clayton Jr. | Director | 10/16/2017 | 71,090 |
Biller Scott | Chief Scientific Officer | 10/04/2017 | 732,900 |
Schenkein David P | Chief Executive Officer | 10/04/2017 | 24,200 |
Schenkein David P | Chief Executive Officer | 10/04/2017 | 5,611,200 |
Biller Scott | Chief Scientific Officer | 10/02/2017 | 40,995 |
Biller Scott | Chief Scientific Officer | 10/02/2017 | 144,276 |
Schenkein David P | Chief Executive Officer | 10/02/2017 | 1,815 |
Schenkein David P | Chief Executive Officer | 10/02/2017 | 400,560 |
Schenkein David P | Chief Executive Officer | 09/18/2017 | 10,588 |
Schenkein David P | Chief Executive Officer | 09/18/2017 | 2,349,200 |
Cantley Lewis Clayton Jr. | Director | 09/13/2017 | 65,470 |
Cantley Lewis Clayton Jr. | Director | 09/13/2017 | 65,470 |
Cantley Lewis Clayton Jr. | Director | 09/14/2017 | 65,710 |
Cantley Lewis Clayton Jr. | Director | 09/14/2017 | 65,710 |
Bowden Christopher | Chief Medical Officer | 09/11/2017 | 210,960 |
Bowden Christopher | Chief Medical Officer | 09/11/2017 | 390,000 |
Biller Scott | Chief Scientific Officer | 09/11/2017 | 975,000 |
Biller Scott | Chief Scientific Officer | 09/01/2017 | 19,421 |
Biller Scott | Chief Scientific Officer | 09/01/2017 | 133,031 |
Schenkein David P | Chief Executive Officer | 09/01/2017 | 1,815 |
Schenkein David P | Chief Executive Officer | 09/01/2017 | 373,200 |
Cantley Lewis Clayton Jr. | Director | 08/23/2017 | 57,080 |
Cantley Lewis Clayton Jr. | Director | 08/23/2017 | 57,080 |
Cantley Lewis Clayton Jr. | Director | 08/22/2017 | 56,620 |
Cantley Lewis Clayton Jr. | Director | 08/22/2017 | 56,620 |
Biller Scott | Chief Scientific Officer | 08/01/2017 | 19,421 |
Biller Scott | Chief Scientific Officer | 08/02/2017 | 1,261,260 |
Biller Scott | Chief Scientific Officer | 08/01/2017 | 118,137 |
Schenkein David P | Chief Executive Officer | 08/02/2017 | 7,260 |
Schenkein David P | Chief Executive Officer | 08/01/2017 | 908 |
Schenkein David P | Chief Executive Officer | 08/02/2017 | 1,453,200 |
Schenkein David P | Chief Executive Officer | 08/01/2017 | 165,360 |
Cantley Lewis Clayton Jr. | Director | 07/20/2017 | 57,125 |
Cantley Lewis Clayton Jr. | Director | 07/20/2017 | 57,125 |
Cantley Lewis Clayton Jr. | Director | 07/19/2017 | 196,505 |
Cantley Lewis Clayton Jr. | Director | 07/19/2017 | 196,505 |
Biller Scott | Chief Scientific Officer | 07/07/2017 | 19,421 |
Biller Scott | Chief Scientific Officer | 07/07/2017 | 118,030 |
Schenkein David P | Chief Executive Officer | 07/03/2017 | 908 |
Schenkein David P | Chief Executive Officer | 07/03/2017 | 153,540 |
Biller Scott | Chief Scientific Officer | 06/23/2017 | 1,403 |
Biller Scott | Chief Scientific Officer | 06/21/2017 | 40,245 |
Biller Scott | Chief Scientific Officer | 06/21/2017 | 236,060 |
Cantley Lewis Clayton Jr. | Director | 06/14/2017 | 25,545 |
Cantley Lewis Clayton Jr. | Director | 06/13/2017 | 25,320 |
Cantley Lewis Clayton Jr. | Director | 06/13/2017 | 25,320 |
Cantley Lewis Clayton Jr. | Director | 06/14/2017 | 25,545 |
Schenkein David P | Chief Executive Officer | 06/07/2017 | 575 |
Schenkein David P | Chief Executive Officer | 06/06/2017 | 333 |
Schenkein David P | Chief Executive Officer | 06/07/2017 | 95,038 |
Schenkein David P | Chief Executive Officer | 06/06/2017 | 55,022 |
Cantley Lewis Clayton Jr. | Director | 05/25/2017 | 23,882 |
Cantley Lewis Clayton Jr. | Director | 05/25/2017 | 23,882 |
Cantley Lewis Clayton Jr. | Director | 05/24/2017 | 24,060 |
Cantley Lewis Clayton Jr. | Director | 05/24/2017 | 24,060 |
Schenkein David P | Chief Executive Officer | 05/01/2017 | 908 |
Schenkein David P | Chief Executive Officer | 05/01/2017 | 150,180 |
Celgene European Investment Co LLC | 10% Owner | 04/24/2017 | 30,916,463 |
Cantley Lewis Clayton Jr. | Director | 04/18/2017 | 25,918 |
Cantley Lewis Clayton Jr. | Director | 04/18/2017 | 25,918 |
Cantley Lewis Clayton Jr. | Director | 04/17/2017 | 112,458 |
Cantley Lewis Clayton Jr. | Director | 04/17/2017 | 112,458 |
Biller Scott | Chief Scientific Officer | 04/03/2017 | 19,421 |
Biller Scott | Chief Scientific Officer | 04/03/2017 | 124,532 |
Schenkein David P | Chief Executive Officer | 04/03/2017 | 908 |
Schenkein David P | Chief Executive Officer | 04/03/2017 | 175,860 |
Cantley Lewis Clayton Jr. | Director | 03/23/2017 | 27,440 |
Cantley Lewis Clayton Jr. | Director | 03/23/2017 | 27,440 |
Cantley Lewis Clayton Jr. | Director | 03/22/2017 | 26,626 |
Cantley Lewis Clayton Jr. | Director | 03/22/2017 | 26,626 |
Biller Scott | Chief Scientific Officer | 03/20/2017 | 53,930 |
Biller Scott | Chief Scientific Officer | 03/20/2017 | 354,090 |
NELSEN ROBERT | Director | 03/06/2017 | 1,977 |
NELSEN ROBERT | Director | 03/03/2017 | 2,062,232 |
NELSEN ROBERT | Director | 02/28/2017 | 2,381,815 |
NELSEN ROBERT | Director | 02/27/2017 | 9,616,080 |
NELSEN ROBERT | Director | 02/22/2017 | 2,392,754 |
NELSEN ROBERT | Director | 02/21/2017 | 1,848,249 |
NELSEN ROBERT | Director | 02/23/2017 | 2,442,461 |
Schenkein David P | Chief Executive Officer | 02/16/2017 | 1,815 |
Schenkein David P | Chief Executive Officer | 02/16/2017 | 300,060 |
Biller Scott | Chief Scientific Officer | 11/14/2016 | 337,037 |
Biller Scott | Chief Scientific Officer | 11/14/2016 | 1,787,500 |
Biller Scott | Chief Scientific Officer | 11/14/2016 | 325,000 |
Biller Scott | Chief Scientific Officer | 11/10/2016 | 127,680 |
Biller Scott | Chief Scientific Officer | 11/09/2016 | 172,320 |
Cantley Lewis Clayton Jr. | Director | 10/27/2016 | 30,606 |
Cantley Lewis Clayton Jr. | Director | 10/27/2016 | 30,704 |
Cantley Lewis Clayton Jr. | Director | 10/26/2016 | 30,569 |
Cantley Lewis Clayton Jr. | Director | 10/26/2016 | 30,667 |
Biller Scott | Chief Scientific Officer | 10/05/2016 | 275,000 |
Cantley Lewis Clayton Jr. | Director | 09/28/2016 | 33,750 |
Cantley Lewis Clayton Jr. | Director | 09/28/2016 | 33,858 |
Cantley Lewis Clayton Jr. | Director | 09/27/2016 | 33,844 |
Cantley Lewis Clayton Jr. | Director | 09/27/2016 | 33,952 |
Biller Scott | Chief Scientific Officer | 09/20/2016 | 250,000 |
Cantley Lewis Clayton Jr. | Director | 08/30/2016 | 23,006 |
Cantley Lewis Clayton Jr. | Director | 08/30/2016 | 23,080 |
Cantley Lewis Clayton Jr. | Director | 08/29/2016 | 23,631 |
Cantley Lewis Clayton Jr. | Director | 08/29/2016 | 23,707 |
Cantley Lewis Clayton Jr. | Director | 07/25/2016 | 26,240 |
Cantley Lewis Clayton Jr. | Director | 07/26/2016 | 27,338 |
Cantley Lewis Clayton Jr. | Director | 07/26/2016 | 27,425 |
Cantley Lewis Clayton Jr. | Director | 07/25/2016 | 26,156 |
Cantley Lewis Clayton Jr. | Director | 06/28/2016 | 27,113 |
Cantley Lewis Clayton Jr. | Director | 06/28/2016 | 27,199 |
Cantley Lewis Clayton Jr. | Director | 06/27/2016 | 25,231 |
Cantley Lewis Clayton Jr. | Director | 06/27/2016 | 25,312 |
Biller Scott | Chief Scientific Officer | 06/08/2016 | 174,766 |
Biller Scott | Chief Scientific Officer | 06/10/2016 | 7,106 |
Biller Scott | Chief Scientific Officer | 06/08/2016 | 1,787,500 |
Cantley Lewis Clayton Jr. | Director | 05/26/2016 | 33,050 |
Cantley Lewis Clayton Jr. | Director | 05/26/2016 | 33,156 |
Cantley Lewis Clayton Jr. | Director | 05/25/2016 | 31,563 |
Cantley Lewis Clayton Jr. | Director | 05/25/2016 | 31,664 |
Cantley Lewis Clayton Jr. | Director | 04/26/2016 | 32,529 |
Cantley Lewis Clayton Jr. | Director | 04/25/2016 | 34,375 |
Cantley Lewis Clayton Jr. | Director | 04/25/2016 | 34,485 |
Cantley Lewis Clayton Jr. | Director | 04/26/2016 | 32,425 |
Cantley Lewis Clayton Jr. | Director | 03/30/2016 | 23,806 |
Cantley Lewis Clayton Jr. | Director | 03/30/2016 | 23,882 |
Cantley Lewis Clayton Jr. | Director | 03/29/2016 | 22,675 |
Cantley Lewis Clayton Jr. | Director | 03/29/2016 | 22,748 |
Cantley Lewis Clayton Jr. | Director | 11/17/2015 | 209,450 |
Cantley Lewis Clayton Jr. | Director | 11/17/2015 | 209,365 |
Cantley Lewis Clayton Jr. | Director | 11/16/2015 | 81,029 |
Cantley Lewis Clayton Jr. | Director | 11/16/2015 | 81,162 |
Cantley Lewis Clayton Jr. | Director | 02/25/2016 | 23,063 |
Cantley Lewis Clayton Jr. | Director | 02/25/2016 | 23,136 |
Cantley Lewis Clayton Jr. | Director | 02/26/2016 | 24,306 |
Cantley Lewis Clayton Jr. | Director | 02/26/2016 | 24,384 |
Biller Scott | Chief Scientific Officer | 02/03/2016 | 4,675 |
Cantley Lewis Clayton Jr. | Director | 01/29/2016 | 25,950 |
Cantley Lewis Clayton Jr. | Director | 01/29/2016 | 26,033 |
Cantley Lewis Clayton Jr. | Director | 01/28/2016 | 27,706 |
Cantley Lewis Clayton Jr. | Director | 01/28/2016 | 27,795 |
Biller Scott | Chief Scientific Officer | 01/07/2016 | 7,013 |
Schenkein David P | Chief Executive Officer | 01/07/2016 | 6,050 |
Biller Scott | Chief Scientific Officer | 12/31/2015 | 174,020 |
Biller Scott | Chief Scientific Officer | 12/31/2015 | 358,985 |
Higgons John Duncan | Chief Operating Officer | 01/04/2016 | 195,925 |
Schenkein David P | Chief Executive Officer | 01/04/2016 | 3,025 |
Schenkein David P | Chief Executive Officer | 01/05/2016 | 3,025 |
Cantley Lewis Clayton Jr. | Director | 12/29/2015 | 176,647 |
Cantley Lewis Clayton Jr. | Director | 12/28/2015 | 169,623 |
Cantley Lewis Clayton Jr. | Director | 12/28/2015 | 169,649 |
Cantley Lewis Clayton Jr. | Director | 12/29/2015 | 176,514 |
Higgons John Duncan | Chief Operating Officer | 12/15/2015 | 1,001,800 |
Biller Scott | Chief Scientific Officer | 11/30/2015 | 174,020 |
Biller Scott | Chief Scientific Officer | 11/30/2015 | 362,945 |
Higgons John Duncan | Chief Operating Officer | 11/16/2015 | 21,764 |
Higgons John Duncan | Chief Operating Officer | 11/16/2015 | 1,230,200 |
Cantley Lewis Clayton Jr. | Director | 11/17/2015 | 209,450 |
Cantley Lewis Clayton Jr. | Director | 11/17/2015 | 209,365 |
Cantley Lewis Clayton Jr. | Director | 11/16/2015 | 72,028 |
Cantley Lewis Clayton Jr. | Director | 11/16/2015 | 72,028 |
Biller Scott | Chief Scientific Officer | 11/02/2015 | 174,020 |
Biller Scott | Chief Scientific Officer | 11/02/2015 | 424,160 |
Schenkein David P | Chief Executive Officer | 10/27/2015 | 126,560 |
Schenkein David P | Chief Executive Officer | 10/27/2015 | 321,040 |
Cantley Lewis Clayton Jr. | Director | 10/22/2015 | 148,495 |
Cantley Lewis Clayton Jr. | Director | 10/23/2015 | 148,229 |
Cantley Lewis Clayton Jr. | Director | 10/23/2015 | 148,253 |
Cantley Lewis Clayton Jr. | Director | 10/22/2015 | 148,520 |
Higgons John Duncan | Chief Operating Officer | 10/15/2015 | 6,244 |
Higgons John Duncan | Chief Operating Officer | 10/15/2015 | 1,420,800 |
Higgons John Duncan | Chief Operating Officer | 09/30/2015 | 3,025 |
Biller Scott | Chief Scientific Officer | 09/30/2015 | 174,020 |
Biller Scott | Chief Scientific Officer | 09/30/2015 | 387,420 |
Goddard Glenn | Senior Vice President, Finance | 09/24/2015 | 431,650 |
Goddard Glenn | Senior Vice President, Finance | 09/24/2015 | 19,774 |
Goddard Glenn | Senior Vice President, Finance | 09/24/2015 | 515,820 |
Cantley Lewis Clayton Jr. | Director | 09/24/2015 | 204,827 |
Cantley Lewis Clayton Jr. | Director | 09/25/2015 | 199,102 |
Cantley Lewis Clayton Jr. | Director | 09/25/2015 | 199,150 |
Cantley Lewis Clayton Jr. | Director | 09/24/2015 | 204,803 |
Higgons John Duncan | Chief Operating Officer | 09/15/2015 | 6,050 |
Higgons John Duncan | Chief Operating Officer | 09/15/2015 | 1,822,200 |
Higgons John Duncan | Chief Operating Officer | 08/20/2015 | 3,025 |
Higgons John Duncan | Chief Operating Officer | 08/17/2015 | 6,050 |
Higgons John Duncan | Chief Operating Officer | 08/17/2015 | 1,844,800 |
Cantley Lewis Clayton Jr. | Director | 08/18/2015 | 232,144 |
Cantley Lewis Clayton Jr. | Director | 08/18/2015 | 232,144 |
Cantley Lewis Clayton Jr. | Director | 08/17/2015 | 228,481 |
Cantley Lewis Clayton Jr. | Director | 08/17/2015 | 228,553 |
Biller Scott | Chief Scientific Officer | 08/10/2015 | 174,020 |
Biller Scott | Chief Scientific Officer | 08/10/2015 | 550,000 |
Higgons John Duncan | Chief Operating Officer | 08/06/2015 | 3,025 |
Schenkein David P | Chief Executive Officer | 08/03/2015 | 231,152 |
Schenkein David P | Chief Executive Officer | 08/03/2015 | 884,800 |
Goddard Glenn | Senior Vice President, Finance | 07/23/2015 | 210,216 |
Goddard Glenn | Senior Vice President, Finance | 07/23/2015 | 843,150 |
Biller Scott | Chief Scientific Officer | 07/20/2015 | 174,020 |
Biller Scott | Chief Scientific Officer | 07/20/2015 | 626,285 |
Goddard Glenn | Senior Vice President, Finance | 07/17/2015 | 76,603 |
Goddard Glenn | Senior Vice President, Finance | 07/17/2015 | 1,478,230 |
Cantley Lewis Clayton Jr. | Director | 07/16/2015 | 276,976 |
Cantley Lewis Clayton Jr. | Director | 07/15/2015 | 277,413 |
Cantley Lewis Clayton Jr. | Director | 07/15/2015 | 277,486 |
Cantley Lewis Clayton Jr. | Director | 07/16/2015 | 277,049 |
Higgons John Duncan | Chief Operating Officer | 07/16/2015 | 6,050 |
Higgons John Duncan | Chief Operating Officer | 07/16/2015 | 2,280,400 |
Biller Scott | Chief Scientific Officer | 05/07/2015 | 529,760 |
Biller Scott | Chief Scientific Officer | 04/08/2015 | 537,020 |
Biller Scott | Chief Scientific Officer | 06/26/2015 | 3,506 |
Cantley Lewis Clayton Jr. | Director | 06/25/2015 | 256,331 |
Cantley Lewis Clayton Jr. | Director | 06/25/2015 | 256,331 |
Cantley Lewis Clayton Jr. | Director | 06/24/2015 | 253,735 |
Cantley Lewis Clayton Jr. | Director | 06/24/2015 | 253,760 |
Biller Scott | Chief Scientific Officer | 06/16/2015 | 140 |
Higgons John Duncan | Chief Operating Officer | 06/15/2015 | 736,610 |
Higgons John Duncan | Chief Operating Officer | 06/12/2015 | 3,025 |
Higgons John Duncan | Chief Operating Officer | 06/11/2015 | 3,025 |
Higgons John Duncan | Chief Operating Officer | 06/10/2015 | 3,025 |
Biller Scott | Chief Scientific Officer | 06/08/2015 | 670,175 |
Schenkein David P | Chief Executive Officer | 06/01/2015 | 1,568,710 |
Bowden Christopher | Chief Medical Officer | 06/01/2015 | 175,800 |
Bowden Christopher | Chief Medical Officer | 06/01/2015 | 603,350 |
Schenkein David P | Chief Executive Officer | 05/27/2015 | 1,071,926 |
Goddard Glenn | Senior Vice President, Finance | 05/27/2015 | 50,150 |
Goddard Glenn | Senior Vice President, Finance | 05/27/2015 | 260,629 |
Cantley Lewis Clayton Jr. | Director | 05/19/2015 | 283,017 |
Cantley Lewis Clayton Jr. | Director | 05/19/2015 | 283,090 |
Cantley Lewis Clayton Jr. | Director | 05/20/2015 | 282,872 |
Cantley Lewis Clayton Jr. | Director | 05/20/2015 | 282,872 |
Higgons John Duncan | Chief Operating Officer | 05/15/2015 | 837,305 |
Schenkein David P | Chief Executive Officer | 05/12/2015 | 230,293 |
Schenkein David P | Chief Executive Officer | 05/11/2015 | 341,801 |
Schenkein David P | Chief Executive Officer | 05/07/2015 | 3,025 |
Schenkein David P | Chief Executive Officer | 05/08/2015 | 395,148 |
Schenkein David P | Chief Executive Officer | 05/01/2015 | 365,157 |
Cantley Lewis Clayton Jr. | Director | 04/24/2015 | 258,345 |
Cantley Lewis Clayton Jr. | Director | 04/24/2015 | 258,248 |
Cantley Lewis Clayton Jr. | Director | 04/23/2015 | 251,892 |
Cantley Lewis Clayton Jr. | Director | 04/23/2015 | 251,867 |
Higgons John Duncan | Chief Operating Officer | 04/15/2015 | 655,272 |
Schenkein David P | Chief Executive Officer | 04/13/2015 | 390,117 |
Schenkein David P | Chief Executive Officer | 04/01/2015 | 360,906 |
Cantley Lewis Clayton Jr. | Director | 03/27/2015 | 233,697 |
Cantley Lewis Clayton Jr. | Director | 03/27/2015 | 233,745 |
Cantley Lewis Clayton Jr. | Director | 03/26/2015 | 220,305 |
Cantley Lewis Clayton Jr. | Director | 03/26/2015 | 220,378 |
Higgons John Duncan | Chief Operating Officer | 03/16/2015 | 743,680 |
Goddard Glenn | Senior Vice President, Finance | 03/16/2015 | 272,624 |
Goddard Glenn | Senior Vice President, Finance | 03/16/2015 | 1,062,400 |
Biller Scott | Chief Scientific Officer | 03/16/2015 | 2,571 |
Biller Scott | Chief Scientific Officer | 03/16/2015 | 587,455 |
Schenkein David P | Chief Executive Officer | 03/05/2015 | 286,416 |
Biller Scott | Chief Scientific Officer | 02/27/2015 | 10,624 |
Schenkein David P | Chief Executive Officer | 02/27/2015 | 7,563 |
Schenkein David P | Chief Executive Officer | 03/02/2015 | 834,990 |
Goddard Glenn | Senior Vice President, Finance | 02/13/2015 | 30,400 |
Goddard Glenn | Senior Vice President, Finance | 02/13/2015 | 158,328 |
Schenkein David P | Chief Executive Officer | 02/13/2015 | 82,292 |
Schenkein David P | Chief Executive Officer | 02/11/2015 | 94,550 |
Goddard Glenn | Senior Vice President, Finance | 02/11/2015 | 34,950 |
Goddard Glenn | Senior Vice President, Finance | 02/09/2015 | 331,237 |
Goddard Glenn | Senior Vice President, Finance | 02/11/2015 | 181,772 |
Goddard Glenn | Senior Vice President, Finance | 02/09/2015 | 1,587,150 |
Schenkein David P | Chief Executive Officer | 02/02/2015 | 1,188,824 |
Biller Scott | Chief Scientific Officer | 01/02/2015 | 2,104 |
Biller Scott | Chief Scientific Officer | 01/02/2015 | 495,360 |
Schenkein David P | Chief Executive Officer | 01/02/2015 | 1,431,040 |
Higgons John Duncan | Chief Operating Officer | 01/02/2015 | 1,320,960 |
Higgons John Duncan | Chief Operating Officer | 01/02/2015 | 1,320,960 |
MARAGANORE JOHN | Director | 12/16/2014 | 200,015 |
Celgene European Investment Co LLC | 10% Owner | 12/16/2014 | 25,322,434 |
Schenkein David P | Chief Executive Officer | 12/01/2014 | 1,261,390 |
Higgons John Duncan | Chief Operating Officer | 12/01/2014 | 1,164,360 |
Biller Scott | Chief Scientific Officer | 12/01/2014 | 2,104 |
Biller Scott | Chief Scientific Officer | 12/01/2014 | 436,635 |
Biller Scott | Chief Scientific Officer | 11/20/2014 | 3,506 |
Schenkein David P | Chief Executive Officer | 11/03/2014 | 1,062,230 |
Goddard Glenn | Senior Vice President, Finance | 11/03/2014 | 16,193 |
Goddard Glenn | Senior Vice President, Finance | 11/03/2014 | 163,420 |
Higgons John Duncan | Chief Operating Officer | 11/03/2014 | 1,062,230 |
Biller Scott | Chief Scientific Officer | 11/03/2014 | 2,104 |
Biller Scott | Chief Scientific Officer | 11/03/2014 | 367,695 |
Schenkein David P | Chief Executive Officer | 10/01/2014 | 756 |
Schenkein David P | Chief Executive Officer | 10/01/2014 | 780,910 |
Higgons John Duncan | Chief Operating Officer | 10/01/2014 | 780,910 |
Biller Scott | Chief Scientific Officer | 10/01/2014 | 2,104 |
Biller Scott | Chief Scientific Officer | 10/01/2014 | 270,315 |
Goddard Glenn | Senior Vice President, Finance | 10/01/2014 | 13,575 |
Goddard Glenn | Senior Vice President, Finance | 10/01/2014 | 90,105 |
Goddard Glenn | Senior Vice President, Finance | 09/26/2014 | 91,222 |
Goddard Glenn | Senior Vice President, Finance | 09/26/2014 | 989,275 |
Schenkein David P | Chief Executive Officer | 09/26/2014 | 9,075 |
Schenkein David P | Chief Executive Officer | 09/26/2014 | 3,760,800 |
Biller Scott | Chief Scientific Officer | 09/19/2014 | 17,763 |
Biller Scott | Chief Scientific Officer | 09/19/2014 | 1,916,898 |
Biller Scott | Chief Scientific Officer | 08/07/2014 | 2,338 |
Biller Scott | Chief Scientific Officer | 09/02/2014 | 2,104 |
Biller Scott | Chief Scientific Officer | 09/02/2014 | 208,350 |
Goddard Glenn | Senior Vice President, Finance | 09/02/2014 | 22,648 |
Goddard Glenn | Senior Vice President, Finance | 09/02/2014 | 463,000 |
Schenkein David P | Chief Executive Officer | 09/02/2014 | 1,966 |
Schenkein David P | Chief Executive Officer | 09/02/2014 | 601,900 |
Higgons John Duncan | Chief Operating Officer | 09/02/2014 | 2,040 |
Higgons John Duncan | Chief Operating Officer | 09/02/2014 | 601,900 |
Higgons John Duncan | Chief Operating Officer | 08/26/2014 | 1,513 |
Higgons John Duncan | Chief Operating Officer | 08/26/2014 | 225,250 |
Schenkein David P | Chief Executive Officer | 08/11/2014 | 181,970 |
Schenkein David P | Chief Executive Officer | 08/01/2014 | 331,770 |
Higgons John Duncan | Chief Operating Officer | 08/01/2014 | 2,118 |
Higgons John Duncan | Chief Operating Officer | 08/01/2014 | 273,630 |
Biller Scott | Chief Scientific Officer | 08/01/2014 | 2,104 |
Biller Scott | Chief Scientific Officer | 08/01/2014 | 175,905 |
Schenkein David P | Chief Executive Officer | 07/01/2014 | 604,760 |
Goddard Glenn | Senior Vice President, Finance | 07/01/2014 | 3,893 |
Goddard Glenn | Senior Vice President, Finance | 07/01/2014 | 162,820 |
Higgons John Duncan | Chief Operating Officer | 07/01/2014 | 558,240 |
Biller Scott | Chief Scientific Officer | 07/01/2014 | 2,104 |
Biller Scott | Chief Scientific Officer | 07/01/2014 | 209,340 |
MARAGANORE JOHN | Director | 06/23/2014 | 101,154 |
Biller Scott | Chief Scientific Officer | 06/20/2014 | 937 |
Biller Scott | Chief Scientific Officer | 06/20/2014 | 100,300 |
Higgons John Duncan | Chief Operating Officer | 06/13/2014 | 226,350 |
Higgons John Duncan | Chief Operating Officer | 06/03/2014 | 129,537 |
Higgons John Duncan | Chief Operating Officer | 06/02/2014 | 111,771 |
Biller Scott | Chief Scientific Officer | 06/02/2014 | 2,104 |
Biller Scott | Chief Scientific Officer | 06/02/2014 | 151,920 |
Higgons John Duncan | Chief Operating Officer | 05/06/2014 | 228,650 |
Goddard Glenn | Senior Vice President, Finance | 05/01/2014 | 2,532 |
Goddard Glenn | Senior Vice President, Finance | 05/01/2014 | 84,780 |
Higgons John Duncan | Chief Operating Officer | 05/01/2014 | 908 |
Higgons John Duncan | Chief Operating Officer | 05/01/2014 | 296,730 |
Biller Scott | Chief Scientific Officer | 05/01/2014 | 6,311 |
Biller Scott | Chief Scientific Officer | 05/01/2014 | 572,265 |
MARAGANORE JOHN | Director | 04/29/2014 | 99,000 |
Celgene European Investment Co LLC | 10% Owner | 04/29/2014 | 12,971,200 |
Higgons John Duncan | Chief Operating Officer | 04/07/2014 | 908 |
Higgons John Duncan | Chief Operating Officer | 04/07/2014 | 135,510 |
Goddard Glenn | Senior Vice President, Finance | 04/07/2014 | 2,315 |
Goddard Glenn | Senior Vice President, Finance | 04/07/2014 | 90,340 |
Goddard Glenn | Senior Vice President, Finance | 04/01/2014 | 2,542 |
Goddard Glenn | Senior Vice President, Finance | 04/01/2014 | 152,320 |
Higgons John Duncan | Chief Operating Officer | 04/01/2014 | 3,630 |
Higgons John Duncan | Chief Operating Officer | 04/01/2014 | 456,960 |
Biller Scott | Chief Scientific Officer | 04/01/2014 | 16,129 |
Biller Scott | Chief Scientific Officer | 04/01/2014 | 171,360 |
Tessier-Lavigne Marc | Director | 07/24/2013 | 999,990 |
MARAGANORE JOHN | Director | 07/24/2013 | 149,994 |
Schenkein David P | Chief Executive Officer | 03/25/2014 | 7,563 |
Higgons John Duncan | Chief Operating Officer | 03/19/2014 | 24,200 |
Schenkein David P | Chief Executive Officer | 03/10/2014 | 16,335 |
Higgons John Duncan | Chief Operating Officer | 03/10/2014 | 6,050 |
Goddard Glenn | Senior Vice President, Finance | 03/07/2014 | 6,123 |
Goddard Glenn | Senior Vice President, Finance | 03/06/2014 | 2,556 |
Goddard Glenn | Senior Vice President, Finance | 03/07/2014 | 541,200 |
Goddard Glenn | Senior Vice President, Finance | 03/06/2014 | 194,333 |
Higgons John Duncan | Chief Operating Officer | 03/07/2014 | 2,723 |
Higgons John Duncan | Chief Operating Officer | 03/06/2014 | 1,708 |
Higgons John Duncan | Chief Operating Officer | 03/06/2014 | 200,659 |
Higgons John Duncan | Chief Operating Officer | 03/07/2014 | 405,900 |
Higgons John Duncan | Chief Operating Officer | 03/03/2014 | 2,420 |
Higgons John Duncan | Chief Operating Officer | 03/03/2014 | 238,832 |
Biller Scott | Chief Scientific Officer | 03/03/2014 | 2,805 |
Biller Scott | Chief Scientific Officer | 03/03/2014 | 179,124 |
Goddard Glenn | Senior Vice President, Finance | 02/18/2014 | 1,651 |
Goddard Glenn | Senior Vice President, Finance | 02/18/2014 | 123,832 |
Higgons John Duncan | Chief Operating Officer | 02/18/2014 | 712 |
Higgons John Duncan | Chief Operating Officer | 02/18/2014 | 82,531 |
Goddard Glenn | Senior Vice President, Finance | 02/10/2014 | 2,805 |
Goddard Glenn | Senior Vice President, Finance | 02/10/2014 | 182,640 |
Higgons John Duncan | Chief Operating Officer | 02/03/2014 | 2,420 |
Higgons John Duncan | Chief Operating Officer | 02/03/2014 | 207,728 |
Biller Scott | Chief Scientific Officer | 02/03/2014 | 2,805 |
Biller Scott | Chief Scientific Officer | 02/03/2014 | 155,796 |
Goddard Glenn | Senior Vice President, Finance | 01/27/2014 | 3,273 |
Goddard Glenn | Senior Vice President, Finance | 01/27/2014 | 184,051 |
Biller Scott | Chief Scientific Officer | 01/21/2014 | 2,805 |
Biller Scott | Chief Scientific Officer | 01/21/2014 | 208,265 |
Higgons John Duncan | Chief Operating Officer | 01/21/2014 | 3,630 |
Higgons John Duncan | Chief Operating Officer | 01/21/2014 | 416,530 |
Goddard Glenn | Senior Vice President, Finance | 01/21/2014 | 4,675 |
Goddard Glenn | Senior Vice President, Finance | 01/21/2014 | 347,108 |
Celgene European Investment Co LLC | 10% Owner | 07/29/2013 | 12,749,994 |
Period of Report: 03/31/2024
10-K/10-Q Filings: View